commit e735ac4318d398e6450250504876b33d0868433f
Author: davidlagorce <david.lagorce@inserm.fr>
Date:   Sun Nov 1 21:11:14 2020 +0100

    NOV 2020

diff --git a/Rare diseases and classifications/Cross-referencing of rare diseases/XML/cs_product1.xml b/Rare diseases and classifications/Cross-referencing of rare diseases/XML/cs_product1.xml
index 06d2885..426cad9 100644
--- a/Rare diseases and classifications/Cross-referencing of rare diseases/XML/cs_product1.xml	
+++ b/Rare diseases and classifications/Cross-referencing of rare diseases/XML/cs_product1.xml	
@@ -1,5 +1,5 @@
 <?xml version="1.0" encoding="UTF-8"?>
-<JDBOR date="2020-10-01 04:26:26" version="1.3.6 / 4.1.7 [2020-04-17] (orientdb version)" copyright="Orphanet (c) 2020" dbserver="jdbc:sybase:Tds:canard.orpha.net:2020">
+<JDBOR date="2020-11-01 04:26:11" version="1.3.6 / 4.1.7 [2020-04-17] (orientdb version)" copyright="Orphanet (c) 2020" dbserver="jdbc:sybase:Tds:canard.orpha.net:2020">
   <Availability> 
     <Licence>
       <FullName lang="en">Creative Commons Attribution 4.0 International</FullName>
@@ -7,7 +7,7 @@
       <LegalCode>https://creativecommons.org/licenses/by/4.0/legalcode</LegalCode>
     </Licence>
   </Availability>
-  <DisorderList count="10478">
+  <DisorderList count="10500">
     <Disorder id="17601">
       <OrphaCode>166024</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=166024</ExpertLink>
@@ -1431,7 +1431,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Type 2A von Willebrand disease (type 2A VWD) is a subtype of type 2 VWD (see this term) characterized by a bleeding disorder associated with a decrease in the affinity of the Willebrand factor (von Willebrand factor; VWF) for platelets and the subendothelium caused by a deficiency of high molecular weight VWF multimers.</Contents>
+              <Contents>A subtype of type 2 von Willebrand disease characterized by a bleeding disorder associated with a decrease in the affinity of the Willebrand factor (VWF) for platelets and the subendothelium caused by a deficiency of high molecular weight VWF multimers. The disease manifests as mucocutaneous bleeding (menorrhagia, epistaxis, gastrointestinal hemorrhage etc.).</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -1769,7 +1769,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Type 2M von Willebrand disease (type 2M VWD) is a subtype of type 2 VWD (see this term) characterized by a bleeding disorder associated with a decrease in the affinity of the Willebrand factor (von Willebrand factor; VWF) for platelets and the subendothelium in the absence of any deficiency of high molecular weight VWF multimers.</Contents>
+              <Contents>A subtype of type 2 von Willebrand disease characterized by a bleeding disorder associated with decreased affinity of the Willebrand factor (VWF) for platelets and the subendothelium in the absence of any deficiency of high molecular weight VWF multimers. The disease manifests as mucocutaneous bleeding (menorrhagia, epistaxis, gastrointestinal hemorrhage etc.).</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -1942,7 +1942,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Type 2B von Willebrand disease (type 2B VWD) is a subtype of type 2 VWD (see this term) characterized by a bleeding disorder associated with an increase in the affinity of the Willebrand factor (von Willebrand factor; VWF) for platelets. This anomaly results in spontaneous binding of high molecular weight VWF multimers to platelets leading to rapid clearance of both the platelets (increasing the risk of thrombocytopenia) and the high molecular weight VWF multimers from the plasma.</Contents>
+              <Contents>A subtype of type 2 von Willebrand disease characterized by a bleeding disorder associated with increased affinity of the Willebrand factor (VWF) for platelets leading to rapid clearance of both the platelets (increasing the risk of thrombocytopenia) and VWF from the plasma. The disease manifests as mucocutaneous bleeding (menorrhagia, epistaxis, gastrointestinal hemorrhage etc.).</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -2118,7 +2118,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Type 2N von Willebrand disease (type 2N VWD) is a subtype of type 2 VWD (see this term) characterized by a bleeding disorder associated with a marked decrease in the affinity of the Willebrand factor (von Willebrand factor; VWF) for factor VIII (FVIII).</Contents>
+              <Contents>A subtype of type 2 von Willebrand disease characterized by a bleeding disorder associated with a marked decrease in the affinity of the Willebrand factor (VWF) for factor VIII (FVIII). Abnormal bleeding manifestations are much less frequent in this VWD subtype than in other forms of the disease.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -6479,7 +6479,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Cystic fibrosis (CF) is a genetic disorder characterized by the production of sweat with a high salt content and mucus secretions with an abnormal viscosity.</Contents>
+              <Contents>A rare, genetic pulmonary disorder characterized by sweat, thick mucus secretions causing multisystem disease, chronic infections of the lungs, bulky diarrhea and short stature.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -30655,7 +30655,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121717" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157760" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare lymphoma characterized by the concurrent occurrence of two or more histologic types of lymphoma involving the same anatomic site. Composite lymphomas can be combinations of two non-Hodgkin lymphomas or of a non-Hodgkin and a Hodgkin lymphoma. In many cases, the tumors are clonally related. Clinical presentation and treatment are determined by the more aggressive component.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="17806">
@@ -31314,7 +31324,14 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="cs">Tento termín neoznačuje nemoc, ale skupinu nemocí. Chcete-li se dozvědět o nemocech zahrnutých v tomto termínu, můžete se obrátit na klasifikace.</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="17800">
@@ -31374,7 +31391,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121645" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157390" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare myeloproliferative neoplasm characterized by a clonal proliferation of eosinophilic precursors with persistent increase of eosinophils in peripheral blood and bone marrow, accompanied by increased blasts (&lt;20%) or clonal cytogenetic or molecular genetic abnormalities. Cases with BCR-ABL1, PCM1-JAK2, ETV6-JAK2, or BCR-JAK2 fusion, or rearrangement of PDGFRA, PDGFRB, or FGFR1, are not included in this entity. Infiltration of the liver and spleen, as well as a variety of other organs, is typical. Patients may present with constitutional symptoms and signs and symptoms of organ involvement, such as endomyocardial fibrosis, peripheral neuropathy, central nervous system manifestations, respiratory symptoms, or rheumatological findings. Acute transformation is common.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="373">
@@ -35152,7 +35179,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Nail-patella syndrome (NPS) is a rare hereditary patellar dysostosis characterized by nail hypoplasia or aplasia, aplastic or hypoplastic patellae, elbow dysplasia, and the presence of iliac horns as well as renal and ocular anomalies.</Contents>
+              <Contents>A rare hereditary patellar dysostosis characterized by nail hypoplasia or aplasia, aplastic or hypoplastic patellae, elbow dysplasia, and the presence of iliac horns as well as renal and ocular anomalies.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -35234,7 +35261,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>An autosomal recessively inherited organic aciduria characterized by a deficiency in isovaleryl-CoA dehydrogenase, that has wide clinical variability and that can present in infancy with acute manifestations of vomiting, failure to thrive, seizures, lethargy, a characteristic ''sweaty feet'' odor, acute pancreatitis and mild to severe developmental delay or in childhood with metabolic acidosis (brought on by prolonged fasting, an increased intake of protein-rich food or infections) and that can be fatal if not treated immediately. Chronic intermittent presentations and asymptomatic patients have also been reported.</Contents>
+              <Contents>A rare, autosomal recessive, organic aciduria that is characterized by variable clinical presentation ranging from acute neonatal onset of metabolic decompensation to later onset of chronic, non-specific manifestations including failure to thrive and/or developmental delay. All patients are prone to intermittent, acute metabolic decompensation. During metabolic episodes, urine analysis demonstrates elevated isovaleric acid derivatives.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -64589,7 +64616,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Eosinophilic granulomatosis with polyangiitis (EGPA), previously known as Churg-Strauss syndrome, is a systemic vasculitis of small-to medium vessels, characterized by asthma, transient pulmonary infiltrates, and hypereosinophilia.</Contents>
+              <Contents>A rare systemic vasculitis of small vessels characterized by asthma, blood and tissue eosinophilia and vasculitis manifestations.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -66681,7 +66708,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Eosinophilic fasciitis is a rare connective tissue disease that is characterized by inflammation and thickening of the fascia, usually associated with peripheral eosinophilia. It presents during adulthood with symmetrical and painful swelling of mainly the extremities that progressively become indurated. Fatigue, disabling cutaneous fibrosis, myositis and arthritis may also be observed.</Contents>
+              <Contents>A rare idiopathic inflammatory myopathy that is characterized by inflammation and thickening of the fascia, usually associated with peripheral eosinophilia. It presents during adulthood with symmetrical and painful swelling of mainly the extremities that progressively become indurated. Fatigue, disabling cutaneous fibrosis, myositis and arthritis may also be observed.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -66835,7 +66862,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Microscopic polyangiitis (MPA) is an inflammatory, necrotizing, systemic vasculitis that affects predominantly small vessels (i.e. small arteries, arterioles, capillaries, venules) in multiple organs.</Contents>
+              <Contents>A rare inflammatory, necrotizing, systemic vasculitis that affects predominantly small vessels (i.e. small arteries, arterioles, capillaries, venules) in multiple organs, including the kidney, the lungs, the skin and the peripheral nerves.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -71580,7 +71607,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121527" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156950" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare, genetic, renal tubular disease characterized by progressive outgrowths of fluid-filled cysts from the renal epithelium, which can manifest with hematuria, urinary tract infections, hypertension, and abdominal or flank pain. The slowly progressive loss of kidney function may evolve to end stage kidney disease (ESKD).</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="18422">
@@ -72290,7 +72327,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Interauricular communication is a congenital malformation characterized by a communication between the atrial chambers of the heart.</Contents>
+              <Contents>A congenital cardiac malformation characterized by a communication between the atrial chambers of the heart.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -73471,7 +73508,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121520" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156942" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare skin tumor characterized by predominantly intraepithelial growth of an adenocarcinoma which may either arise primarily in the skin (primary extramammary Paget disease) or result from intraepithelial spread of a visceral carcinoma (secondary extramammary Paget disease). The lesion is typically located in the anogenital region, presenting as a scaly, oozing, pruritic or painful erythematous plaque often resembling eczema. It may exhibit an invasive component with a significant risk of lymph node metastasis.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="18401">
@@ -80635,7 +80682,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Complete atrioventricular canal (CAVC), also referred to as complete atrioventricular septal defect, is characterized by an ostium primum atrial septal defect, a common atrioventricular valve and a variable deficiency of the ventricular septum inflow.</Contents>
+              <Contents>A rare, congenital cardiac anomaly characterized by a common atrioventricular junction with a common AV valve, an interatrial communication just above the common AV valve (ostium primum defect), a posterior interventricular communication (inlet VSD), that results in shunting at both the atrial and ventricular level. Morphologically, the common atrioventricular valve has 4 or 5 leaflets including superior and inferior bridging leaflets with a single annulus.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -96650,7 +96697,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>A rare, mostly benign, primary tumor of the meninges (arachnoid cap cells), usually located in the supratentorial compartment, commonly appearing in the sixth and seventh decade of life, clinically silent in most cases or causing hyperostosis close to the tumor and resulting in focal bulging and localized pain in less than 10% of cases. Additional features may include headache, seizures, gradual personality changes (apathy and dementia), anosmia, impaired vision, exophthalmos, hearing loss, ataxia, dysmetria, hypotonia, nystagmus, and rarely spontaneous bleeding.</Contents>
+              <Contents>A rare, mostly benign, neoplastic disease characterized by a primary tumor of the meninges, usually located intracranially (~90%) but spinal meningiomas occur as well. Clinical symptoms relate to the location of the tumor and may include seizures, focal neurological deficits (sensory-motor or visual symptoms, cranial nerve dysfunction), vascular complications (occlusion of cerebral blood vessels, deep venous thrombosis, pulmonary embolism), chronically increased intracranial pressure neurocognitive impairment and/or loss of bladder/anus sphincter control.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -117562,7 +117609,11 @@
       <OrphaCode>1133</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=1133</ExpertLink>
       <Name lang="cs">AREDYLD syndrom</Name>
-      <DisorderFlagList count="1">
+      <DisorderFlagList count="2">
+        <DisorderFlag id="460">
+          <Value>512</Value>
+          <Label>Historical entity</Label>
+        </DisorderFlag>
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
@@ -121689,7 +121740,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121395" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156323" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare benign vascular tumor characterized by rapid growth after birth (followed by spontaneous partial regression over the course of years), potentially leading to life-threatening airway obstruction due to the subglottic location. Patients present with respiratory symptoms including biphasic stridor, recurrent croup, cyanosis, apnea, and sternal and intercostal retractions. The tumor may be accompanied by cutaneous hemangiomata, especially in the lower facial ("beard") distribution.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="1642">
@@ -132870,7 +132931,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Cardiofaciocutaneous (CFC) syndrome is a RASopathy characterized by craniofacial dysmorphism, congenital heart disease, dermatological abnormalities (most commonly hyperkeratotic skin and sparse, curly hair), growth retardation and intellectual disability.</Contents>
+              <Contents>A rare, multiple congenital anomalies syndrome characterized by craniofacial dysmorphology, congenital heart disease, dermatological abnormalities (most commonly hyperkeratotic skin and sparse, curly hair), neurological manifestations (hypotonia, seizures), failure to thrive and intellectual disability.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -138768,7 +138829,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>A rare, genetic congenital limb malformation disorder characterized by hypoplasia/aplasia of distal and/or middle phalanges in fingers and toes II-V (frequently severe in fingers/toes IV-V, milder in fingers/toes II-III) in association with proximal, and occasionally distal, symphalangism, fusion of carpal/tarsal bones and partial cutaneous syndactyly. Additional reported features include proximal placement of thumbs, sensorineural hearing loss and farsightedness.</Contents>
+              <Contents>A clinical subtype of brachydactyly type B characterized by hypoplasia/aplasia of distal and/or middle phalanges in fingers and toes II-V (frequently severe in fingers/toes IV-V, milder in fingers/toes II-III) in association with proximal, and occasionally distal, symphalangism, fusion of carpal/tarsal bones and partial cutaneous syndactyly. Additional reported features include proximal placement of thumbs, sensorineural hearing loss and farsightedness.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -139778,7 +139839,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>A rare neurologic disease characterized by focal and diffuse neurologic symptoms due to vasculitis of the intracerebral blood vessels. Most common manifestations are insidiously progressive headaches and cognitive impairment, in addition to stroke and transient ischemic attacks, seizures, aphasia, and visual field deficits, among others. Signs of vasculitis outside the central nervous system are rare, serologic markers of inflammation are typically normal. Cerebrospinal fluid analysis may reveal elevations in total protein level and cell count.</Contents>
+              <Contents>A rare, medium or small vessel vasculitis characterized by focal and/or diffuse neurologic symptoms due to a documented arteritic process in the central nervous system, in the absence of other identified underlying cause (infectious, systemic, other neurologic diseases, etc.). It presents with non-specific symptoms of headache, stroke or transient ischemic attacks with cognitive impairment, hemiplegia, weakness, and rarely, with cranial nerve involvement, seizures and ataxia.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -142816,7 +142877,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Teebi type hypertelorism is a rare genetic disease characterized by hypertelorism with facial features that can closely resemble craniofrontonasal dysplasia (see this term), such as prominent forehead, widow's peak, heavy and broad eyebrows, long palpebral fissures, ptosis, high and broad nasal bridge, short nose, low-set ears, natal teeth, thin upper lip and a grooved chin, as well as limb (i.e. fifth-finger clinodactyly, pes adductus, mild interdigital webbing), urogenital (i.e. bilateral cryptorchidism and shawl scrotum in males) and umbilical (i.e. hernia/small omphalocele) anomalies and cardiac (i.e. ventricular or atrial septal defect, patent ductus arteriosus) defects. Additional findings such as polycystic kidneys and iridochorioretinal colobomas have also been reported and psychomotor development is normal. The facial features can also resemble Aarskog and Opitz G/BBB syndromes (see these terms).</Contents>
+              <Contents>A rare autosomal dominant malformation syndrome characterized by hypertelorism, omphalocoele, cleft lip, ear pits, uterine malformation (bicornuate uterus), and more variably by diaphragmatic hernia and congenital heart defects.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -154218,7 +154279,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>A multiple congenital anomalies (MCA) syndrome involving connective tissue characterized by Growth retardation, Alopecia, Pseudoanodontia and Ocular manifestations.</Contents>
+              <Contents>A rare, genetic, multiple congenital anomalies syndrome characterized by growth retardation, alopecia, pseudoanodontia and ocular manifestations.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -161440,7 +161501,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Idiopathic eosinophilic myositis is a rare skeletal muscle disease characterized by eosinophilic infiltration and inflammatory lesions of the skeletal muscle tissue, in the absence of an identifiable causative factor (e.g. parasitic infection, drug intake, systemic or malignant disease). Clinically patients may present focal or generalized muscle weakness and pain, difficulties to walk, motor clumsiness and/or mild bilateral aquilae retraction, as well as elevated serum creatine kinase levels and peripheral blood and/or bone marrow hypereosinophilia.</Contents>
+              <Contents>A rare idiopathic inflammatory myopathy characterized by eosinophilic infiltration and inflammatory lesions of the skeletal muscle tissue, in the absence of an identifiable causative factor (e.g. parasitic infection, drug intake, systemic or malignant disease). Clinically patients may present focal or generalized muscle weakness and pain, difficulties to walk, motor clumsiness and/or mild bilateral aquilae retraction, as well as elevated serum creatine kinase levels and peripheral blood and/or bone marrow hypereosinophilia.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -161489,7 +161550,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Inflammatory myopathy with abundant macrophages is a rare inflammatory myopathy characterized by diffuse destructive infiltration of CD68+ macrophages into the fascia rather than muscle fibers in muscle biopsies, proximal muscle weakness and myalgia with or without scaly dermatomyositis-like or atypical non-dermatomyositis-like skin lesions, elevation of creatine kinase levels and thickening of muscle fascia in muscle MRI.</Contents>
+              <Contents>A rare idiopathic inflammatory myopathy characterized by diffuse destructive infiltration of CD68+ macrophages into the fascia rather than muscle fibers in muscle biopsies, proximal muscle weakness and myalgia with or without scaly dermatomyositis-like or atypical non-dermatomyositis-like skin lesions, elevation of creatine kinase levels and thickening of muscle fascia in muscle MRI.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -165850,9 +165911,9 @@
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=247839</ExpertLink>
       <Name lang="cs">Letální syndrom podobný Larsenovu</Name>
       <DisorderFlagList count="1">
-        <DisorderFlag id="475">
-          <Value>1</Value>
-          <Label></Label>
+        <DisorderFlag id="455">
+          <Value>16</Value>
+          <Label>Obsolete entity</Label>
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="2">
@@ -165865,31 +165926,21 @@
       <DisorderGroup id="36554">
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="1">
-        <ExternalReference id="121887">
-          <Source>ICD-10</Source>
-          <Reference>M08.4</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="cs">Ověřeno</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="11710">
+            <OrphaCode>85410</OrphaCode>
+            <Name lang="en">Oligoarticular juvenile idiopathic arthritis</Name>
+          </TargetDisorder>
+          <RootDisorder id="19555" cycle="true"/>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="cs">Odkazuje na</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="1">
-        <SummaryInformation id="-1" lang="en">
-          <TextSectionList count="0">
-          </TextSectionList>
-          <TextAuto>
-            <Info lang="cs">Toto onemocnění je popsáno v  Letální syndrom podobný Larsenovu</Info>
-          </TextAuto>
-        </SummaryInformation>
+      <SummaryInformationList count="0">
       </SummaryInformationList>
     </Disorder>
     <Disorder id="2210">
@@ -166058,9 +166109,9 @@
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=247861</ExpertLink>
       <Name lang="cs">Juvenilní revmatoidní faktor-negativní polyartritida bez antinukleárních protilátek</Name>
       <DisorderFlagList count="1">
-        <DisorderFlag id="475">
-          <Value>1</Value>
-          <Label></Label>
+        <DisorderFlag id="455">
+          <Value>16</Value>
+          <Label>Obsolete entity</Label>
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="1">
@@ -166072,31 +166123,21 @@
       <DisorderGroup id="36554">
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="1">
-        <ExternalReference id="121890">
-          <Source>ICD-10</Source>
-          <Reference>M08.3</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="cs">Ověřeno</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="11709">
+            <OrphaCode>85408</OrphaCode>
+            <Name lang="en">Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis</Name>
+          </TargetDisorder>
+          <RootDisorder id="19558" cycle="true"/>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="cs">Odkazuje na</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="1">
-        <SummaryInformation id="-1" lang="en">
-          <TextSectionList count="0">
-          </TextSectionList>
-          <TextAuto>
-            <Info lang="cs">Toto onemocnění je popsáno v  Juvenilní revmatoidní faktor-negativní polyartritida bez antinukleárních protilátek</Info>
-          </TextAuto>
-        </SummaryInformation>
+      <SummaryInformationList count="0">
       </SummaryInformationList>
     </Disorder>
     <Disorder id="2215">
@@ -166260,9 +166301,9 @@
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=247846</ExpertLink>
       <Name lang="cs">Oligoartikulární juvenilní artritida bez antinukleárních protilátek</Name>
       <DisorderFlagList count="1">
-        <DisorderFlag id="475">
-          <Value>1</Value>
-          <Label></Label>
+        <DisorderFlag id="455">
+          <Value>16</Value>
+          <Label>Obsolete entity</Label>
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="1">
@@ -166274,31 +166315,21 @@
       <DisorderGroup id="36554">
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="1">
-        <ExternalReference id="121888">
-          <Source>ICD-10</Source>
-          <Reference>M08.4</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="cs">Ověřeno</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="11710">
+            <OrphaCode>85410</OrphaCode>
+            <Name lang="en">Oligoarticular juvenile idiopathic arthritis</Name>
+          </TargetDisorder>
+          <RootDisorder id="19556" cycle="true"/>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="cs">Odkazuje na</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="1">
-        <SummaryInformation id="-1" lang="en">
-          <TextSectionList count="0">
-          </TextSectionList>
-          <TextAuto>
-            <Info lang="cs">Toto onemocnění je popsáno v  Oligoartikulární juvenilní artritida bez antinukleárních protilátek</Info>
-          </TextAuto>
-        </SummaryInformation>
+      <SummaryInformationList count="0">
       </SummaryInformationList>
     </Disorder>
     <Disorder id="2213">
@@ -166377,9 +166408,9 @@
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=247854</ExpertLink>
       <Name lang="cs">Juvenilní idiopatická polyartritida s negativním revmatoidním faktorem s antinukleárními protilátkami</Name>
       <DisorderFlagList count="1">
-        <DisorderFlag id="475">
-          <Value>1</Value>
-          <Label></Label>
+        <DisorderFlag id="461">
+          <Value>1024</Value>
+          <Label>Obsolete with resources</Label>
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="1">
@@ -166391,31 +166422,11 @@
       <DisorderGroup id="36554">
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="1">
-        <ExternalReference id="121889">
-          <Source>ICD-10</Source>
-          <Reference>M08.3</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="cs">Ověřeno</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="0">
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="1">
-        <SummaryInformation id="-1" lang="en">
-          <TextSectionList count="0">
-          </TextSectionList>
-          <TextAuto>
-            <Info lang="cs">Toto onemocnění je popsáno v  Juvenilní idiopatická polyartritida s negativním revmatoidním faktorem s antinukleárními protilátkami</Info>
-          </TextAuto>
-        </SummaryInformation>
+      <SummaryInformationList count="0">
       </SummaryInformationList>
     </Disorder>
     <Disorder id="2268">
@@ -172347,7 +172358,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Mowat-Wilson syndrome (MWS) is a multiple congenital anomaly syndrome characterized by a distinct facial phenotype, intellectual disability, epilepsy, Hirschsprung disease (HSCR; see this term) and variable congenital malformations.</Contents>
+              <Contents>A rare multiple congenital anomaly syndrome characterized by a distinct facial phenotype, intellectual disability, epilepsy, Hirschsprung disease (HSCR) and variable congenital malformations.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -184632,9 +184643,9 @@
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=254793</ExpertLink>
       <Name lang="cs">Porucha mitochondriální oxidativní fosforylace způsobená duplikací mitochondriální DNA</Name>
       <DisorderFlagList count="1">
-        <DisorderFlag id="475">
-          <Value>1</Value>
-          <Label></Label>
+        <DisorderFlag id="455">
+          <Value>16</Value>
+          <Label>Obsolete entity</Label>
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="3">
@@ -184650,9 +184661,26 @@
       </DisorderGroup>
       <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="19772">
+            <OrphaCode>254758</OrphaCode>
+            <Name lang="en">Mitochondrial oxidative phosphorylation disorder due to mitochondrial DNA anomalies</Name>
+          </TargetDisorder>
+          <RootDisorder id="19776" cycle="true"/>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="cs">Odkazuje na</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="cs">Tento termín neoznačuje nemoc, ale skupinu nemocí. Chcete-li se dozvědět o nemocech zahrnutých v tomto termínu, můžete se obrátit na klasifikace.</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="2432">
@@ -192475,9 +192503,9 @@
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=252175</ExpertLink>
       <Name lang="cs">Vestibulární schwannom</Name>
       <DisorderFlagList count="1">
-        <DisorderFlag id="475">
-          <Value>1</Value>
-          <Label></Label>
+        <DisorderFlag id="461">
+          <Value>1024</Value>
+          <Label>Obsolete with resources</Label>
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="3">
@@ -192491,56 +192519,11 @@
       <DisorderGroup id="36554">
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="3">
-        <ExternalReference id="122098">
-          <Source>UMLS</Source>
-          <Reference>C0027859</Reference>
-          <DisorderMappingRelation id="21527">
-            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation/>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="cs">Ověřeno</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
-        <ExternalReference id="122099">
-          <Source>MedDRA</Source>
-          <Reference>10000523</Reference>
-          <DisorderMappingRelation id="21527">
-            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation/>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="cs">Ověřeno</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
-        <ExternalReference id="130222">
-          <Source>ICD-10</Source>
-          <Reference>D33.3</Reference>
-          <DisorderMappingRelation id="21527">
-            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21583">
-            <Name lang="en">Specific code (The ORPHA code has its own code in the ICD10)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="cs">Ověřeno</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="0">
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="1">
-        <SummaryInformation id="76348" lang="en">
-          <TextSectionList count="1">
-            <TextSection id="88406" lang="en">
-              <TextSectionType id="16907">
-                <Name lang="cs">Definice</Name>
-              </TextSectionType>
-              <Contents>Vestibular schwannoma is a rare tumor of the posterior fossa originating in the Schwann cells of the vestibular transitional zone of the vestibulocochlear nerve that can be benign, small, slow growing and asymptomatic or large, faster growing and aggressive and potentially fatal, presenting with symptoms of hearing and balance impairment, vertigo, ataxia, headache and fifth, sixth or seventh cranial nerve dysfunction and facial numbness.</Contents>
-            </TextSection>
-          </TextSectionList>
-        </SummaryInformation>
+      <SummaryInformationList count="0">
       </SummaryInformationList>
     </Disorder>
     <Disorder id="19756">
@@ -194946,7 +194929,17 @@
       </DisorderGroup>
       <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="19772" cycle="true"/>
+          <RootDisorder id="19776">
+            <OrphaCode>254793</OrphaCode>
+            <Name lang="en">OBSOLETE: Mitochondrial oxidative phosphorylation disorder due to a duplication of mitochondrial DNA</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="cs">Odkazuje na</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="0">
       </SummaryInformationList>
@@ -204394,7 +204387,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Myhre syndrome is characterised by striking muscular build, short stature, reduced joint mobility, brachydactyly, mixed hearing loss and mental retardation of variable severity. Facial dysmorphism with short palpebral fissures, short philtrum, thin lips, maxillary hypoplasia and prognathism is present. Thick skin has been observed in six patients.</Contents>
+              <Contents>A rare multiple congenital anomalies syndrome characterized by muscular pseudohypertrophy, short stature, reduced joint mobility, brachydactyly, mixed hearing loss and intellectual disability of variable severity. Facial dysmorphism with short palpebral fissures, short philtrum, thin lips, maxillary hypoplasia and prognathism is present. Thick skin has been observed.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -251709,7 +251702,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>An inherited bleeding disorder due to reduced activity of factor II (FII, prothrombin) and characterized by mucocutaneous bleeding symptoms.</Contents>
+              <Contents>A rare inherited bleeding disorder due to reduced activity of factor II (FII, prothrombin) and characterized by mucocutaneous and soft tissue bleeding symptoms.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -258397,7 +258390,17 @@
           </DisorderDisorderAssociationType>
         </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121593" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157279" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare inherited cancer-predisposing syndrome characterized by predisposition to a wide variety of cancers, including neoplasms of the digestive tract, urinary tract, kidney, endometrium, ovary, brain, and prostate, as well as sebaceous skin tumors, depending on the gene involved. Tumors may occur at any age but often arise in young people. Factors influencing individual tumor risk include sex, age, affected gene, and personal history of cancer.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="18540">
@@ -267507,7 +267510,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>A rare neoplastic disease and the most common primary liver cancer of adulthood, characterized by hepatic mass, abdominal pain and, in advanced stages, jaundice, cachexia and liver failure. Derived from well-differentiated hepatocytes, it often develops from chronic liver cirrhosis which is most often due to hepatitis B and C virus or alcohol abuse.</Contents>
+              <Contents>A rare carcinoma of the liver characterized by one to several or many nodules occurring anywhere within the liver, composed of neoplastic epithelial cells with hepatocellular differentiation. The vast majority of tumors are associated with chronic liver disease (such as hepatitis B or C, or steatohepatitis) or exposure to a variety of exogenous agents. Patients may present with signs and symptoms related to the tumor, as well as to the underlying condition. Common manifestations include right upper quadrant abdominal pain, weight loss, hepatosplenomegaly, jaundice, and ascites. Symptomatic tumors generally have poor prognosis.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -271860,7 +271863,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Rhizomelic chondrodysplasia is a form chondrodysplasia punctata (see this term), a group of diseases in which the common characteristic is calcifications near joints at birth.</Contents>
+              <Contents>A rare, primary bone dysplasia characterized by rhizomelic limb shortening, punctate calcifications in cartilage with epiphyseal and metaphyseal abnormalities (chondrodysplasia punctata) and coronal cleft vertebrae associated with profound postnatal growth deficiency, early-onset cataracts, severe intellectual disability and seizures.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -280919,7 +280922,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Polyarteritis nodosa (PAN) is a rare, clinically heterogeneous, rheumatologic disease characterized by necrotizing inflammatory lesions affecting small- and medium-sized blood vessels. PAN most commonly affects skin, joints, peripheral nerves, the gut, and the kidney.</Contents>
+              <Contents>A rare, clinically heterogeneous, systemic disease characterized by necrotizing inflammatory lesions affecting medium-sized blood vessels. It most commonly affects skin, joints, peripheral nerves and the gastrointestinal tract.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -286070,7 +286073,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121387" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156315" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare congenital non-syndromic heart malformation characterized by a communication between the ascending aorta and the pulmonary trunk in the presence of two normally formed semilunar valves. It may be an isolated finding or occur in association with other anomalies. Severe clinical manifestations, such as congestive heart failure or pulmonary hypertension, typically develop in early life.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="18865">
@@ -302895,7 +302908,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Congenital factor X deficiency is an inherited bleeding disorder with a decreased antigen and/or activity of factor X (FX) and characterized by mild to severe bleeding symptoms.</Contents>
+              <Contents>A rare inherited bleeding disorder with a decreased antigen and/or activity of factor X (FX) and characterized by mild to severe bleeding symptoms.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -305471,7 +305484,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121473" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156810" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare renal disease characterized by excess urinary calcium excretion in the absence of an underlying systemic disease. The condition leads to an increased risk for the formation of kidney stones and nephrocalcinosis, as well as reduced bone mineral density with increased incidence of fractures.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="19175">
@@ -305972,9 +305995,9 @@
             <Name lang="cs">Ověřeno</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="112142">
+        <ExternalReference id="185250">
           <Source>ICD-10</Source>
-          <Reference>D47.4</Reference>
+          <Reference>D47.7</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
@@ -308695,7 +308718,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Ehlers-Danlos syndrome due to tenascin-X deficiency is a type of Ehlers-Danlos syndrome characterized by generalized joint hypermobility, skin hyperextensibility and easy bruising without atrophic scarring. Other common features include foot and hand deformities (piezogenic papules, pes planus, broad forefeet, brachydactyly, and acrogenic skin of hands), severe fatigue and neuromuscular symptoms including muscle weakness and myalgia.</Contents>
+              <Contents>A form of Ehlers-Danlos syndrome characterized by generalized joint hypermobility, skin hyperextensibility and easy bruising without atrophic scarring. Other common features include foot and hand deformities (piezogenic papules, pes planus, broad forefeet, brachydactyly, and acrogeric skin of hands), severe fatigue and neuromuscular symptoms including muscle weakness and myalgia.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -315880,7 +315903,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121470" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156807" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare genetic renal disease characterized by the formation of intraglomerular lipoprotein thrombi due to lipid deposition in severely dilated glomerular capillaries. Laboratory examination reveals abnormal serum lipid profiles, in particular markedly elevated apolipoprotein E. Clinical manifestations include proteinuria or nephrotic syndrome with hypertension and potential progression to chronic renal failure. Systemic complications of dyslipidemia are not observed.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="21938">
@@ -316199,7 +316232,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Juvenile overlap myositis is a rare juvenile idiopathic inflammatory myopathy characterized by the association of inflammatory myositis (manifesting with acral erythema, progressive weakness of the limbs, pain, general fatigue, moodiness or crankiness) with clinical and/or laboratory features of other autoimmune diseases (e.g. systemic lupus erythematosus, localized scleroderma, diabetes). Cardiac involvement has been reported in some patients.</Contents>
+              <Contents>A rare juvenile idiopathic inflammatory myopathy characterized by the association of inflammatory myositis (manifesting with acral erythema, progressive weakness of the limbs, pain, general fatigue, moodiness or crankiness) with clinical and/or laboratory features of other autoimmune diseases (e.g. systemic lupus erythematosus, localized scleroderma, diabetes). Cardiac involvement has been reported in some patients.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -318233,7 +318266,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Congenital factor XI deficiency is an inherited bleeding disorder characterized by reduced levels and activity of factor XI (FXI) resulting in moderate bleeding symptoms, usually occurring after trauma or surgery.</Contents>
+              <Contents>A rare inherited bleeding disorder characterized by reduced levels and/or activity of factor XI (FXI) resulting in moderate bleeding symptoms, usually occurring after trauma or surgery.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -342598,7 +342631,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121471" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156808" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare acquired skin disease characterized by excessive mucin deposition and thickened collagen bundles in the dermis, resulting in woody, non-pitting induration of the skin of the neck, spreading to the shoulders and upper trunk, but sparing hands and feet. According to the association with preceding or underlying conditions, three types can be distinguished: type 1 usually follows a febrile infection, type 2 is associated with paraproteinemia, and type 3 occurs in patients with diabetes mellitus. Especially in types 2 and 3, extracutaneous involvement may be present. Other potentially associated conditions include a variety of endocrinopathies, systemic diseases, and neoplasms.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="22113">
@@ -348843,7 +348886,17 @@
           </DisorderDisorderAssociationType>
         </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121382" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156301" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare congenital limb malformation characterized by complete or partial duplication of one of the three middle digits in a hand or foot. It most commonly affects the fourth digit. The malformation may be unilateral or bilateral and can occur as an isolated defect or in association with other anomalies.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="20950">
@@ -350696,7 +350749,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121642" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157387" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare aggressive B-cell non-Hodgkin lymphoma characterized by neoplastic cells resembling B immunoblasts or plasmablasts with a CD20-negative plasmacytic phenotype. The tumor may occur in the oral cavity, the gastrointestinal tract, or other, predominantly extranodal, sites and is typically associated with immunodeficiency or -suppression. The tumor cells are EBV-positive in most cases. Patients often present with disseminated bone involvement. Paraproteinemia may also be detected. Prognosis is generally poor.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="20754">
@@ -368394,7 +368457,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121491" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156904" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare genetic disorder of lipid metabolism characterized by neonatal to childhood onset of impaired absorption of dietary fat with greasy/oily and voluminous stools, but normal growth and development. Decreased levels of fecal elastase, as well as low serum levels of the fat-soluble vitamins A, D, and E, have been reported.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="21341">
@@ -372249,7 +372322,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Multiple congenital anomalies-hypotonia-seizures syndrome type 2 is a rare, genetic, lethal, neurometabolic malformation syndrome characterized by multiple, variable, congenital cardiac (systolic murmur, atrial septal defect), urinary (duplicated collecting system, vesicoureteral reflux) and central nervous system (thin corpus callosum, cerebellar hypoplasia) malformations associated with neonatal hypotonia, early-onset epileptic encephalopathy, and myoclonic seizures. Craniofacial dysmorphism (prominent occiput, enlarged fontanel, fused metopic suture, upslanted palpebral fissures, overfolded helix, depressed nasal bridge, anteverted nose, malar flattening, microstomy with downturned corners, Pierre-Robin sequence, high arched palate, short neck) and other manifestions (joint contractures, hyperreflexia, dysplastic nails, developmental delay) are also observed.</Contents>
+              <Contents>A rare, genetic, lethal, neurometabolic malformation syndrome characterized by multiple, variable, congenital cardiac (systolic murmur, atrial septal defect), urinary (duplicated collecting system, vesicoureteral reflux) and central nervous system (thin corpus callosum, cerebellar hypoplasia) malformations associated with neonatal hypotonia, early-onset epileptic encephalopathy, and myoclonic seizures. Craniofacial dysmorphism (prominent occiput, enlarged fontanel, fused metopic suture, upslanted palpebral fissures, overfolded helix, depressed nasal bridge, anteverted nose, malar flattening, microstomy with downturned corners, Pierre-Robin sequence, high arched palate, short neck) and other manifestations (joint contractures, hyperreflexia, dysplastic nails, developmental delay) are also observed.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -372267,8 +372340,8 @@
       </DisorderFlagList>
       <SynonymList count="0">
       </SynonymList>
-      <DisorderType id="21394">
-        <Name lang="cs">Onemocnění</Name>
+      <DisorderType id="21401">
+        <Name lang="cs">Malformační syndrom</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="cs">Onemocnění</Name>
@@ -373437,9 +373510,9 @@
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=306436</ExpertLink>
       <Name lang="cs">Vrozený deficit sacharázy-izomaltázy s intolerancí škrobu</Name>
       <DisorderFlagList count="1">
-        <DisorderFlag id="475">
-          <Value>1</Value>
-          <Label></Label>
+        <DisorderFlag id="455">
+          <Value>16</Value>
+          <Label>Obsolete entity</Label>
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="4">
@@ -373454,31 +373527,21 @@
       <DisorderGroup id="36554">
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="1">
-        <ExternalReference id="123269">
-          <Source>ICD-10</Source>
-          <Reference>E74.3</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="cs">Ověřeno</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="10373">
+            <OrphaCode>35122</OrphaCode>
+            <Name lang="en">Congenital sucrase-isomaltase deficiency</Name>
+          </TargetDisorder>
+          <RootDisorder id="21213" cycle="true"/>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="cs">Odkazuje na</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="1">
-        <SummaryInformation id="-1" lang="en">
-          <TextSectionList count="0">
-          </TextSectionList>
-          <TextAuto>
-            <Info lang="cs">Toto onemocnění je popsáno v  Vrozený deficit sacharázy-izomaltázy s intolerancí škrobu</Info>
-          </TextAuto>
-        </SummaryInformation>
+      <SummaryInformationList count="0">
       </SummaryInformationList>
     </Disorder>
     <Disorder id="21212">
@@ -373535,9 +373598,9 @@
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=306462</ExpertLink>
       <Name lang="cs">Vrozený deficit sacharázy-izomaltázy bez intolerance škrobu</Name>
       <DisorderFlagList count="1">
-        <DisorderFlag id="475">
-          <Value>1</Value>
-          <Label></Label>
+        <DisorderFlag id="455">
+          <Value>16</Value>
+          <Label>Obsolete entity</Label>
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="4">
@@ -373552,31 +373615,21 @@
       <DisorderGroup id="36554">
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="1">
-        <ExternalReference id="123272">
-          <Source>ICD-10</Source>
-          <Reference>E74.3</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="cs">Ověřeno</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="10373">
+            <OrphaCode>35122</OrphaCode>
+            <Name lang="en">Congenital sucrase-isomaltase deficiency</Name>
+          </TargetDisorder>
+          <RootDisorder id="21215" cycle="true"/>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="cs">Odkazuje na</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="1">
-        <SummaryInformation id="-1" lang="en">
-          <TextSectionList count="0">
-          </TextSectionList>
-          <TextAuto>
-            <Info lang="cs">Toto onemocnění je popsáno v  Vrozený deficit sacharázy-izomaltázy bez intolerance škrobu</Info>
-          </TextAuto>
-        </SummaryInformation>
+      <SummaryInformationList count="0">
       </SummaryInformationList>
     </Disorder>
     <Disorder id="21214">
@@ -373584,9 +373637,9 @@
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=306446</ExpertLink>
       <Name lang="cs">Vrozený deficit sacharázy-izomaltázy s minimální tolerancí škrobu</Name>
       <DisorderFlagList count="1">
-        <DisorderFlag id="475">
-          <Value>1</Value>
-          <Label></Label>
+        <DisorderFlag id="455">
+          <Value>16</Value>
+          <Label>Obsolete entity</Label>
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="4">
@@ -373601,31 +373654,21 @@
       <DisorderGroup id="36554">
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="1">
-        <ExternalReference id="123270">
-          <Source>ICD-10</Source>
-          <Reference>E74.3</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="cs">Ověřeno</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="10373">
+            <OrphaCode>35122</OrphaCode>
+            <Name lang="en">Congenital sucrase-isomaltase deficiency</Name>
+          </TargetDisorder>
+          <RootDisorder id="21214" cycle="true"/>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="cs">Odkazuje na</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="1">
-        <SummaryInformation id="-1" lang="en">
-          <TextSectionList count="0">
-          </TextSectionList>
-          <TextAuto>
-            <Info lang="cs">Toto onemocnění je popsáno v  Vrozený deficit sacharázy-izomaltázy s minimální tolerancí škrobu</Info>
-          </TextAuto>
-        </SummaryInformation>
+      <SummaryInformationList count="0">
       </SummaryInformationList>
     </Disorder>
     <Disorder id="21230">
@@ -374341,9 +374384,9 @@
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=306474</ExpertLink>
       <Name lang="cs">Vrozený deficit sacharázy-izomaltázy s intolerancí škrobu a laktózy</Name>
       <DisorderFlagList count="1">
-        <DisorderFlag id="475">
-          <Value>1</Value>
-          <Label></Label>
+        <DisorderFlag id="455">
+          <Value>16</Value>
+          <Label>Obsolete entity</Label>
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="4">
@@ -374358,31 +374401,21 @@
       <DisorderGroup id="36554">
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="1">
-        <ExternalReference id="123274">
-          <Source>ICD-10</Source>
-          <Reference>E74.3</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="cs">Ověřeno</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="10373">
+            <OrphaCode>35122</OrphaCode>
+            <Name lang="en">Congenital sucrase-isomaltase deficiency</Name>
+          </TargetDisorder>
+          <RootDisorder id="21216" cycle="true"/>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="cs">Odkazuje na</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="1">
-        <SummaryInformation id="-1" lang="en">
-          <TextSectionList count="0">
-          </TextSectionList>
-          <TextAuto>
-            <Info lang="cs">Toto onemocnění je popsáno v  Vrozený deficit sacharázy-izomaltázy s intolerancí škrobu a laktózy</Info>
-          </TextAuto>
-        </SummaryInformation>
+      <SummaryInformationList count="0">
       </SummaryInformationList>
     </Disorder>
     <Disorder id="21217">
@@ -374390,9 +374423,9 @@
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=306486</ExpertLink>
       <Name lang="cs">Vrozený deficit sacharázy-izomaltázy bez intolerance sacharózy</Name>
       <DisorderFlagList count="1">
-        <DisorderFlag id="475">
-          <Value>1</Value>
-          <Label></Label>
+        <DisorderFlag id="455">
+          <Value>16</Value>
+          <Label>Obsolete entity</Label>
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="3">
@@ -374406,31 +374439,21 @@
       <DisorderGroup id="36554">
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="1">
-        <ExternalReference id="123275">
-          <Source>ICD-10</Source>
-          <Reference>E74.3</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="cs">Ověřeno</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="10373">
+            <OrphaCode>35122</OrphaCode>
+            <Name lang="en">Congenital sucrase-isomaltase deficiency</Name>
+          </TargetDisorder>
+          <RootDisorder id="21217" cycle="true"/>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="cs">Odkazuje na</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="1">
-        <SummaryInformation id="-1" lang="en">
-          <TextSectionList count="0">
-          </TextSectionList>
-          <TextAuto>
-            <Info lang="cs">Toto onemocnění je popsáno v  Vrozený deficit sacharázy-izomaltázy bez intolerance sacharózy</Info>
-          </TextAuto>
-        </SummaryInformation>
+      <SummaryInformationList count="0">
       </SummaryInformationList>
     </Disorder>
     <Disorder id="21247">
@@ -379571,7 +379594,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121713" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157732" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare genetic, multiple congenital anomalies syndrome characterized by short stature, hand brachydactyly with hypoplastic distal phalanges, global development delay, intellectual disability, and more variably seizures, obesity, and craniofacial dysmorphism that includes microcephaly, high forehead, flat face, hypertelorism, deep set eyes, flat nasal bridge, averted nostrils, long philtrum, thin lip vermilion, and short neck.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="24015">
@@ -379795,7 +379828,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121509" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156932" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare vascular anomaly characterized by congenital, solitary or grouped, red-to-purple plaques which may bleed and enlarge over time. The lesions show a predilection for the lower extremities. Histological examination reveals numerous dilated, congested capillaries and venules in the papillary dermis, often with a deep dermal component, and with increased density of variably congested capillaries and venules also in the subcutaneous tissue. The overlying epidermis displays prominent acanthosis, papillomatosis, hyperkeratosis, parakeratosis, and crusting.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="24016">
@@ -381301,7 +381344,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121571" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157232" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare plasma cell neoplasm characterized by peripheral plasmacytosis, usually with extensive and diffuse infiltration of the bone marrow, and monoclonal paraproteinemia. Neoplastic plasma cells may also be found in extramedullary sites, such as the liver or spleen, among others. Most cases present as primary plasma cell leukemia without previous diagnosis of myeloma. The condition can also represent leukemic transformation of plasma cell myeloma (secondary plasma cell leukemia). Clinical manifestations include lymphadenopathy, organomegaly, renal failure, bone marrow failure, and peripheral neuropathies. High serum levels of lactate dehydrogenase and beta2-microglobulin, as well as hypercalcemia (potentially leading to hypercalcemic crisis) are typically observed.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="23663">
@@ -381350,7 +381403,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121519" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156941" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare tumor of salivary glands characterized by a benign, well-circumscribed, slow-growing, painless mass most commonly occurring in the parotid gland (but also the palate, submandibular gland, or nasal septal mucosa), histopathologically composed of epithelial and myoepithelial / stromal components. Possible signs and symptoms depend on the location of the tumor and include facial nerve weakness, mild dysphagia, or unilateral nasal obstruction. Recurrence rates are low, although tumor rupture and spillage have been reported. Malignant transformation may occur in a small percentage of cases.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="23661">
@@ -381400,7 +381463,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121398" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156326" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare, congenital, esophageal malformation characterized by the presence of an abnormal connection between the esophagus and the trachea (typically occuring in the lower cervical or upper thoracic area and taking an oblique path upward to trachea), without concomitant esophageal atresia. Depending on the size of the lumen, presentation varies from neonatal episodes of choking and cyanosis on feeding to subtle symptoms of wheezing and recurrent respiratory infections in childhood or early adulthood.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="23660">
@@ -389349,7 +389422,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121467" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156785" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare intestinal disease characterized by chronic or relapsing subileus or ileus resulting from multiple unexplained fibrous strictures and multiple shallow (i. e. limited to the mucosa or submucosa) ulcerations of the small intestine (mainly the ileum), in the absence of signs of a systemic inflammatory reaction. Patients may present with chronic iron-deficiency anemia due to chronic intestinal blood loss, chronic recurrent abdominal pain, fatigue, edema, or growth retardation. Extraintestinal manifestations such as sicca syndrome, polyarthralgia, or Raynaud's phenomenon may also be observed.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="24225">
@@ -389527,7 +389610,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome is a rare, genetic, syndromic intellecutal disability disorder characterized by craniofacial dysmorphism (microcephaly, hypotonic facies, strabismus, long and flat malar region, posteriorly rotated ears, flat nasal bridge with broad nasal tip, short philtrum, thin vermillion border, open mouth with down-turned corners, high arched palate, pointed chin), global developmental delay, intellectual disability and variable neurobehavioral abnormalities (autism spectrum disorder, aggressivness, self injury). Additional features include vision abnormalities and variable sensorineural hearing loss, as well as short stature, hypotonia and gastrointestinal manifestations (e.g. poor feeding, gastroesophageal reflux, constipation).</Contents>
+              <Contents>A rare, genetic, syndromic intellectual disability disorder characterized by craniofacial features, global developmental delay, intellectual disability and variable neurobehavioral abnormalities (autism spectrum disorder, aggressiveness, and self-injury). Additional features include vision abnormalities and variable sensorineural hearing loss, as well as short stature, hypotonia and gastrointestinal manifestations (e.g. poor feeding, gastroesophageal reflux, constipation).</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -396872,7 +396955,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121394" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156322" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare intestinal disease characterized by potentially life-threatening inflammatory bowel necrosis predominantly affecting preterm neonates. Patients may present with feeding intolerance, lethargy, temperature instability, abdominal distention, blood-stained stools, diarrhea, bilious vomiting, apnea, and signs of sepsis. Radiographic features include pneumatosis intestinalis, portal venous gas, presence of fixed, dilated intestinal loops, bowel wall edema, and (in case of bowel perforation) pneumoperitoneum.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="22641">
@@ -406347,7 +406440,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121472" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156809" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare genetic cardiac disease characterized by variably expressed atrial tachyarrhythmia (such as atrial flutter, paroxysmal or chronic atrial fibrillation, ectopic atrial tachycardia, or multifocal atrial tachycardia), infra-Hisian conduction system disease, and vulnerability to dilated cardiomyopathy. Age of onset ranges between childhood and adulthood.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="23337">
@@ -408781,7 +408884,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121719" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157762" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare benign eye tumor characterized by the presence of glial cells, vascular tissue, and sheets of pigment epithelial cells lacking the distribution and organization of the normal retina and retinal pigment epithelium. The lesion is most commonly found unilaterally as a slightly elevated mass in a peripapillary location but can also occur in the macula or the retinal periphery. It is sometimes associated with neurofibromatosis type 1 or 2, nevoid basal cell carcinoma syndrome, or branchio-oculo-facial syndrome. Patients may be asymptomatic or present with progressive loss of vision.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="23415">
@@ -411628,7 +411741,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121592" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157269" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare tumor characterized by a rapidly growing mass usually arising along the midline, defined by the presence of &lt;i&gt;NUTM1&lt;/i&gt; rearrangements. Histopathological examination shows a poorly differentiated carcinoma, often with evidence of squamous differentiation. Patients present with unspecific signs and symptoms due to mass effect, depending on the location. Extensive local invasion of adjacent structures, lymph node involvement, and distant metastatic disease are often present at the time of diagnosis. Prognosis is generally poor.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="8022">
@@ -412030,7 +412153,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121680" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157603" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare B-cell non-Hodgkin lymphoma characterized by the presence of small B-lymphocytes, plasmacytoid lymphocytes, and plasma cells, and either non-secreting or secreting IgG or IgA paraproteins. The disease usually involves the bone marrow, sometimes also the spleen or lymph nodes. Patients typically present with symptoms related to anemia. Hyperviscosity, autoimmune phenomena, and B symptoms may also be observed. Mortality is higher as compared to WaldenstrÃ¶m macroglobulinemia.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="23444">
@@ -413416,7 +413549,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>A rare genetic multiple congenital anomalies/dysmorphic syndrome characterized by cerebellar hypoplasia, proportionate short stature and microcephaly of prenatal onset, variable degrees of intellectual disability with speech delay, prominent upper incisors, malocclusion, taurodontism, and other dental anomalies, scoliosis, and facial dysmorphism (sparse eyebrows, wave-shaped palpebral fissures, and low-set ears). Additional reported manifestations include ocular, laryngeal, and cardiac abnormalities, as well as additional brain anomalies, such as thin corpus callosum, enlarged ventricles and/or cisterna magna, and hypoplastic pons and mesencephalon.</Contents>
+              <Contents>A rare, autosomal recessive, multiple congenital anomalies/dysmorphic syndrome characterized mainly by developmental delay, variable intellectual disability, microcephaly, cerebellar hypoplasia, dysmorphic features (central incisors macrodontia and slender fingers), short stature and variable congenital anomalies.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -413851,7 +413984,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121383" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156302" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare organic aciduria characterized by increased urinary excretion of 3-methylglutaconic acid, variably associated with neutropenia (sometimes causing recurrent severe infections and potentially resulting in leukemia) and progressive neurologic manifestations, such as global developmental delay, intellectual disability, hypotonia, movement disorder, and seizures. Microcephaly, cataract, facial dysmorphism, growth retardation, endocrine abnormalities, and cardiomyopathy have also been reported. Brain imaging may show cerebral or cerebellar atrophy, or abnormalities of the basal ganglia.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="23515">
@@ -414698,7 +414841,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121548" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157079" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare odontogenic tumor characterized by an unilocular or multilocular cyst most commonly located in the posterior body and lower ramus of the mandible, often surrounding the crown of the third molar. Histopathologically, the lesion shows a lining of parakeratinized stratified squamous epithelium with palisading hyperchromatic basal cells. Patients may be asymptomatic or present with local infection and/or signs and symptoms of mass effect. Recurrence is rare after complete surgical removal. Some patients have multiple cysts (metachronous or synchronous), especially in the context of nevoid basal cell carcinoma syndrome (Gorlin syndrome).</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="23537">
@@ -421929,7 +422082,17 @@
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="8768" cycle="true"/>
+          <RootDisorder id="14473">
+            <OrphaCode>99900</OrphaCode>
+            <Name lang="en">Long chain acyl-CoA dehydrogenase deficiency</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="cs">Přesunuto do</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
         <SummaryInformation id="14244" lang="en">
@@ -422612,7 +422775,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Biliary atresia is a rare, progressive obliterative cholangiopathy of the extrahepatic bile ducts, occuring in the embryonic/ perinatal period, leading to severe and persistent jaundice and acholic stool with an unfavorable course in the absence of treatment.</Contents>
+              <Contents>A rare, biliary tract disease characterized by progressive obliterative cholangiopathy of the intra- and extrahepatic bile ducts, occuring in the embryonic/ perinatal period, leading to severe and persistent neonatal jaundice and acholic stool.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -426544,7 +426707,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121396" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156324" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare organic aciduria characterized by neonatal onset of hypotonia, recurrent apneic episodes, lack of psychomotor development, feeding difficulties, extrapyramidal signs, and seizures. Other reported features include microcephaly, sensorineural deafness, bradycardia, and neutropenia. Laboratory studies show increased serum lactate and urinary excretion of 3-methylglutaconic acid. Brain imaging may reveal progressive cerebral atrophy. The disease is lethal in infancy.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="8721">
@@ -427331,7 +427504,17 @@
           </DisorderDisorderAssociationType>
         </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121468" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156786" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare familial intestinal malformation characterized by failure of the rotation of the developing gastrointestinal tract around the superior mesenteric artery during embryonic development, resulting in a spectrum of abnormalities of intestinal position and fixation. Patients most typically present in the neonatal period with midgut volvulus, which can lead to short bowel syndrome or even death. Signs and symptoms include bilious vomiting, feeding intolerance, failure to thrive, constipation, bloody stools, or intermittent apnea. The condition may also manifest later in life with complications like kinking or hernias and a broad range of intestinal symptoms. It can be an isolated finding or occur in association with other anomalies.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="26573">
@@ -428216,7 +428399,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121723" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157766" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare functioning neuroendocrine tumor of pancreas characterized by a typically well-differentiated neoplasm composed of cells expressing serotonin. Patients may present with atypical carcinoid syndrome with abdominal pain, diarrhea, weight loss, and/or flushing. Carcinoid syndrome is usually present only when there are liver metastases. The tumors tend to be larger than non-functioning tumors and are associated with a poorer prognosis because they are almost always metastatic.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="26437">
@@ -428246,7 +428439,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121679" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157602" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare neuroendocrine neoplasm of pancreas characterized by a high-grade malignant epithelial tumor with neuroendocrine differentiation. Based on histopathologic appearance, a small cell (composed of diffuse sheets of cells) and a large cell type (showing a nesting/trabecular pattern) are distinguished. Synaptophysin and chromogranin are positive on immunohistochemistry. The Ki-67 proliferation index is typically very high (&gt;60 - 80%). Patients present with back pain, jaundice, and/or non-specific abdominal symptoms. Serum hormone activity is unusual. The tumor is highly aggressive with poor prognosis.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="26438">
@@ -428274,7 +428477,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121678" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157601" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare neuroendocrine neoplasm of pancreas characterized by morphologically recognizable neuroendocrine and non-neuroendocrine components, each constituting at least 30% of the tumor volume. Based on histopathology, mixed ductal- and mixed acinar-neuroendocrine carcinomas are distinguished. Patients usually present with unspecific symptoms related to tumor growth and/or metastasis, although occurrence of Zollinger-Ellison syndrome has been reported. Resectability of the tumor is the most important prognostic factor.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="26439">
@@ -428409,7 +428622,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121681" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157604" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare neuroendocrine tumor of pancreas characterized by a well-differentiated epithelial pancreatic neuroendocrine neoplasm measuring at least 0.5 cm, without distinct hormonal syndrome. Tumors &lt;0.5 cm are called microadenomas. Microadenomatosis is the multifocal occurrence of microadenomas. Histopathologic examination shows an organoid growth pattern and expression of synaptophysin and chromogranin A on immunohistochemistry. Tumors are often discovered incidentally, or patients may present with symptoms related to local or metastatic tumor spread. Microadenomas are considered benign, while larger tumors may behave in a malignant manner with extrapancreatic spread, metastasis, or recurrence.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="25773">
@@ -428642,7 +428865,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121722" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157765" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare neoplastic disease characterized by infantile to childhood onset of evidence of bone marrow insufficiency/failure associated with increased risk for myelodysplastic syndrome or acute myeloid leukemia. Most patients present with petechiae, easy bruising, or anemia. Rapid progression is common, and prognosis is generally poor.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="25835">
@@ -429502,7 +429735,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121724" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157767" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare head and neck tumor characterized by a malignant epithelial neoplasm with evidence of squamous differentiation, most commonly located in the piriform sinus, less frequently the posterior pharyngeal wall or the postcricoid area. The tumor can spread directly to adjacent structures or metastasize via lymphatic and blood vessels to regional lymph nodes, or lung, liver, and bones, respectively. Primary risk factors are tobacco smoking and (to a lesser extent) alcohol consumption. Patients may present with odynophagia, dysphagia, signs and symptoms related to a neck mass, voice changes, otalgia, and constitutional symptoms.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="25682">
@@ -429656,7 +429899,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121718" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157761" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare head and neck tumor characterized by a malignant epithelial neoplasm with evidence of squamous differentiation, most commonly located in the supraglottis or glottis. The tumor can spread directly to adjacent structures or metastasize via lymphatic and blood vessels to regional lymph nodes, or lung, liver, and bones, respectively. Primary risk factors are tobacco smoking and (to a lesser extent) alcohol consumption. Patients may present with hoarseness, dyspnea, stridor, dysphagia, hemoptysis, or odynophagia.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="26004">
@@ -431332,7 +431585,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121596" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157300" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare overgrowth syndrome associated with multiple congenital anomalies characterized by tall stature, large hands and feet with large thumbs and halluces, spatulate digits, developmental delay and facial dysmorphism.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="25994">
@@ -431846,7 +432109,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121644" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157389" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare unclassified acute myeloid leukemia characterized by a proliferation of immature cells exclusively of the erythroid lineage without a significant myeloblastic component. Microscopically, the cells may be undifferentiated or proerythroblastic in appearance. Patients may present with pancytopenia with fatigue, infections, and mucocutaneous bleedings, as well as weight loss, fever, and night sweats. Prognosis is poor.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="8561">
@@ -434324,7 +434597,17 @@
           </DisorderDisorderAssociationType>
         </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121591" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157268" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare head and neck tumor characterized by a firm infiltrative neoplasm with squamous differentiation, arising from the mucosal epithelium, and most commonly located in the tongue, floor of the mouth, or gingiva, but also the buccal mucosa or any other area of the oral cavity, depending on prevailing risk factors (such as smoking, alcohol consumption, and tobacco chewing). Patients present with a variably white, erythematous, mixed, nodular, or ulcerated lesion, which may cause discomfort, pain, or reduced mobility of the tongue. The tumor is aggressive with a propensity for local invasion and early lymph node metastasis.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="26074">
@@ -434360,7 +434643,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121590" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157267" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare head and neck tumor characterized by a firm infiltrative neoplasm with squamous differentiation, most commonly arising at the vermilion border of the lower lip. Patients present with a usually asymptomatic lesion of variable appearance, such as ulceration, a focus of whitish thickening, a dry atrophic area, or an area of persistent chapping and localized flaking and crusting. Carcinomas of the lower lip tend to progress slowly (as opposed to those of the upper lip). Invasion of adjacent structures, including perineural spread, is typical, with a variable rate of metastasis, depending on the location.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="26075">
@@ -439156,7 +439449,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Parathyroid carcinoma (PRTC) is a very rare, slow-growing, clinically serious endocrine tumor that generally develops in mid-adulthood. PRTC presents as a palpable painless mass in the neck and causes severe hypercalcemia and related symptoms, non-specific gastrointestinal manifestations, as well as renal and bone complications related to primary hyperparathyroidism (nephrolithiasis, impaired renal function, osteoporosis, bone pain, and pathologic fractures, etc.). Some PRTCs are however non-functioning tumors.</Contents>
+              <Contents>A rare endocrine tumor characterized by a malignant neoplasm derived from parathyroid parenchymal cells, localized in one of the normally located parathyroid glands or other sites where parathyroid tissue may be present. Signs and symptoms are predominantly due to excess secretion of parathyroid hormone, with marked hypercalcemia and renal and bone involvement. In rare cases, the tumor may be non-functioning and only present as a palpable mass in the neck region. Recurrent laryngeal nerve paralysis is also observed. The tumor can occur sporadically or on a genetic background. The extent of invasion of adjacent structures positively correlates with the development of recurrent or metastatic disease.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -440289,7 +440582,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>A congenital heart malformation characterized by an atrial septal defect (ASD; ostium primum), clefts of mitral and occasionally tricuspid valves, two separate atrioventricular (AV) valve annuli and an intact ventricular septum. The typical symptoms of PAVC are impaired exercise capacity and exertional dyspnea.</Contents>
+              <Contents>A rare congenital cardiac malformation that is a variant of an atrioventricular septal defect (AVSD) with an interatrial communication (ostium primum defect) just above the common atrioventricular (AV) valve, no interventricular communication just below the atrioventricular valve, a common atrioventricular junction but separate right and left atrioventricular valvar orifices, and a three-leaflet, left-sided component of the common atrioventricular valve (''cleft''). Shunting is restricted to the atrial level because of fusion of the leaflets of the common AV valve with the crest of the ventricular septum.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -443016,7 +443309,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121512" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156934" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare skin tumor characterized by an asymptomatic, solitary, often ulcerated nodule most commonly located in the face, involving the deep dermis, subcutaneous tissue, and skeletal muscle and fascia. Histopathologically, the lesion is composed of aggregates of atypical basaloid cells with numerous mitoses. Typical features include shadow cells, keratin cysts, and trichohyalin and keratohyalin granules. The tumor is locally aggressive and shows a tendency to recur after incomplete excision. Regional lymph node or visceral metastasis has been reported.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="8620">
@@ -443693,7 +443996,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Cutaneous leukocytoclastic angiitis is a small-vessel vasculitis presenting with palpable purpura and urticarial lesions which predate the purpuric lesions most frequently observed on the legs. Systemic symptoms including fever, cough, hemoptysis, sinusitis, arthralgia, arthritis, myalgia, abdominal pain, diarrhea, hematochezia, paresthesia, weakness, and hematuria may be observed. Skin biopsy reveals exudates rich in neutrophils, endothelial damage, fibrin deposition, and leukocytoclasis in postcapillary venules of small vessels. Cutaneous leukocytoclastic angiitis can be idiopathic (in up to 50% of cases) or secondary to infections, medications (such as antituberculosis medication), collagen vascular diseases, or neoplasms.</Contents>
+              <Contents>A small vessel vasculitis characterized by neutrophilic inflammation predominantly limited to the superficial cutaneous postcapillary venules and without systemic vasculitis or glomerulonephritis. Typical presentation is of unifocal or multifocal palpable purpura on the lower extremities.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -444383,7 +444686,8 @@
           <Label></Label>
         </DisorderFlag>
       </DisorderFlagList>
-      <SynonymList count="0">
+      <SynonymList count="1">
+        <Synonym lang="en">TANGO2-related metabolic encephalopathy-arrhythmia syndrome</Synonym>
       </SynonymList>
       <DisorderType id="21394">
         <Name lang="cs">Onemocnění</Name>
@@ -444895,7 +445199,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121490" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156903" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare bone tumor characterized by a benign, cystic lesion consisting of blood-filled cavities divided by fibrous septa containing fibroblasts, multinucleated osteoclast-type giant cells, and reactive woven bone. The tumor may arise &lt;i&gt;de novo&lt;/i&gt; or secondarily, complicating other benign or malignant bone tumors. It most commonly arises during the first two decades of life and often affects the epiphyses of long bones and posterior elements of vertebral bodies. Patients typically present with pain and swelling, or neurological symptoms due to compression of nerve roots or the spinal cord by vertebral tumors.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="25217">
@@ -444949,7 +445263,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121643" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157388" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare aggressive B-cell non-Hodgkin lymphoma characterized by a rearrangement in MYC and BCL2 and/or BCL6 (so-called double-hit or triple-hit lymphoma). The category includes double-hit cases with features intermediate between diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma, blastoid cases with a double-hit, and cases with a DLBCL, not otherwise specified, morphology with a double-hit. It refers only to &lt;i&gt;de novo&lt;/i&gt; cases, not to lymphomas with a history of pre-existing or coexistent indolent lymphoma. Patients typically present with widespread disease, including involvement of lymph nodes, bone marrow, and central nervous system.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="9793">
@@ -448069,7 +448393,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121650" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157396" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare inherited cancer-predisposing syndrome characterized by adult onset of hematologic malignancies mainly affecting the myeloid lineage (such as myelodysplastic syndrome and/or acute myeloid leukemia), less frequently lymphoid malignancies. Some patients have been reported to develop granulomatous or immune disorders (including sarcoidosis, systemic lupus erythematosus, asthma, eczema, or juvenile arthritis) before or in the absence of hematologic malignancies.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="25414">
@@ -449024,7 +449358,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121397" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156325" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare gastroenterologic disease characterized by the histopathological finding of a thickened (&gt; 10 Âµm) gastric subepithelial collagen layer in association with an inflammatory infiltrate in the lamina propria. Patients typically present with upper abdominal pain and severe iron deficiency anemia. The condition is not commonly associated with autoimmune diseases, and involvement of the colon is less frequent than in the adult form. The disease takes a generally benign course with limited long-term morbidity and no increased mortality.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="25371">
@@ -460869,7 +461213,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>A rare autoimmune bullous skin disease characterized by pruritus with or without polymorphic skin eruptioneruptions, affecting pregnant women typically during the second and third trimester. Skin eruptions may include erythematous papules and plaques, erythema multiforme-like or eczematous lesions, papulovesicles, and bullae, and typically affects the umbilicus, abdomen, and extremities.</Contents>
+              <Contents>A rare autoimmune bullous skin disease characterized by pruritus with or without polymorphic skin eruptions, affecting pregnant women typically during the second and third trimester. Skin eruptions may include erythematous papules and plaques, erythema multiforme-like or eczematous lesions, papulovesicles, and bullae, and typically affect the umbilicus, abdomen, and extremities.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -462179,7 +462523,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121389" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156317" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare bone disease characterized by avascular necrosis of a metatarsal head, most commonly involving the second, but also the third or fourth, metatarsal. Patients may present with pain on weight-bearing, swelling, and tenderness. Radiological features include widening of the metatarsophalangeal joint space and flattening of the affected metatarsal head, at later stages metatarsal head sclerosis, cortical thickening, and intra-articular loose bodies. The condition can be bilateral in some cases and shows a significant predilection for females in the second or third decade of life.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="10797">
@@ -469655,7 +470009,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>A syndrome associating neonatal diabetes, congenital hypothyroidism, congenital glaucoma, hepatopathy evolving to fibrosis and polykystic kidneys has been described in two sibs. Minor facial anomalies were also observed. Two other families presented incomplete forms of this syndrome. Mutations in &lt;i&gt;GLIS3&lt;/i&gt; encoding for the transcription factor GLI similar 3 seem to be responsible of the syndrome.</Contents>
+              <Contents>A rare genetic disease characterized by intrauterine growth retardation, permanent neonatal diabetes mellitus, and congenital hypothyroidism. Additional manifestations include congenital glaucoma, hepatic disease (hepatitis, fibrosis, and cirrhosis), polycystic kidneys, exocrine pancreatic dysfunction, sensorineural hearing impairment, developmental delay, and mild facial dysmorphism (such as flat nasal bridge, epicanthal folds, long philtrum, and low-set ears), among others.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -476005,10 +476359,14 @@
       <OrphaCode>77243</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=77243</ExpertLink>
       <Name lang="cs">Lipedém</Name>
-      <DisorderFlagList count="1">
-        <DisorderFlag id="475">
-          <Value>1</Value>
-          <Label></Label>
+      <DisorderFlagList count="2">
+        <DisorderFlag id="456">
+          <Value>32</Value>
+          <Label>Non-rare disease in Europe</Label>
+        </DisorderFlag>
+        <DisorderFlag id="455">
+          <Value>16</Value>
+          <Label>Obsolete entity</Label>
         </DisorderFlag>
       </DisorderFlagList>
       <SynonymList count="0">
@@ -476019,67 +476377,11 @@
       <DisorderGroup id="36547">
         <Name lang="cs">Onemocnění</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="4">
-        <ExternalReference id="115081">
-          <Source>UMLS</Source>
-          <Reference>C0398370</Reference>
-          <DisorderMappingRelation id="21527">
-            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation/>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="cs">Ověřeno</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
-        <ExternalReference id="115082">
-          <Source>MedDRA</Source>
-          <Reference>10063955</Reference>
-          <DisorderMappingRelation id="21527">
-            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation/>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="cs">Ověřeno</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
-        <ExternalReference id="115085">
-          <Source>ICD-10</Source>
-          <Reference>E65</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="cs">Ověřeno</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
-        <ExternalReference id="56009">
-          <Source>OMIM</Source>
-          <Reference>614103</Reference>
-          <DisorderMappingRelation id="21527">
-            <Name lang="en">E (Exact mapping: the two concepts are equivalent)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation/>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="cs">Ověřeno</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
+      <ExternalReferenceList count="0">
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="1">
-        <SummaryInformation id="114621" lang="en">
-          <TextSectionList count="1">
-            <TextSection id="143487" lang="en">
-              <TextSectionType id="16907">
-                <Name lang="cs">Definice</Name>
-              </TextSectionType>
-              <Contents>A rare genetic subcutaneous tissue disorder almost exclusively occurring in females, characterized by abnormal symmetrical deposition of subcutaneous fat in the lower extremities, beginning at the hips and extending to the ankles, but typically sparing the feet. The condition is accompanied by pain and easy bruising in the affected areas.</Contents>
-            </TextSection>
-          </TextSectionList>
-        </SummaryInformation>
+      <SummaryInformationList count="0">
       </SummaryInformationList>
     </Disorder>
     <Disorder id="11103">
@@ -478571,7 +478873,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121517" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156939" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare soft tissue tumor characterized by a slow-growing, usually painless, subcutaneous nodule, predominantly located in the extremities, less frequently the trunk or head and neck region. Histopathologically, the lesion is well-circumscribed, lobulated, and composed of epitheloid, ovoid, or spindle cells arranged in a nodular and often syncytial pattern, with pseudoangiomatoid spaces and a peripheral fibrous pseudocapsule with a prominent lymphoplasmacytic cuff. The tumor is most common in the first two decades of life and usually follows an indolent course, although local recurrence may occur, while metastasis is rare.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="11016">
@@ -479041,7 +479353,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121649" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157395" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare benign ovarian stromal tumor characterized by a stromal neoplasm with variable microcystic morphology, low mitotic activity, and diffuse nuclear beta-catenin and cyclin D1 immunoreactivity, while inhibin and calretinin are not expressed. Patients most commonly present with symptoms of a unilateral pelvic mass. Hormonal manifestations are usually absent. The tumor may be associated with familial adenomatous polyposis.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="11037">
@@ -483355,7 +483677,57 @@
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="5">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="10373" cycle="true"/>
+          <RootDisorder id="21213">
+            <OrphaCode>306436</OrphaCode>
+            <Name lang="en">OBSOLETE: Congenital sucrase-isomaltase deficiency with starch intolerance</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="cs">Odkazuje na</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="10373" cycle="true"/>
+          <RootDisorder id="21214">
+            <OrphaCode>306446</OrphaCode>
+            <Name lang="en">OBSOLETE: Congenital sucrase-isomaltase deficiency with minimal starch tolerance</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="cs">Odkazuje na</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="10373" cycle="true"/>
+          <RootDisorder id="21215">
+            <OrphaCode>306462</OrphaCode>
+            <Name lang="en">OBSOLETE: Congenital sucrase-isomaltase deficiency without starch intolerance</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="cs">Odkazuje na</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="10373" cycle="true"/>
+          <RootDisorder id="21216">
+            <OrphaCode>306474</OrphaCode>
+            <Name lang="en">OBSOLETE: Congenital sucrase-isomaltase deficiency with starch and lactose intolerance</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="cs">Odkazuje na</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="10373" cycle="true"/>
+          <RootDisorder id="21217">
+            <OrphaCode>306486</OrphaCode>
+            <Name lang="en">OBSOLETE: Congenital sucrase-isomaltase deficiency without sucrose intolerance</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="cs">Odkazuje na</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
         <SummaryInformation id="16472" lang="en">
@@ -485199,7 +485571,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Combined deficiency of factor V and factor VIII is an inherited bleeding disorder due to the reduction in activity and antigen levels of both factor V (FV) and factor VIII (FVIII) and characterized by mild-to-moderate bleeding symptoms.</Contents>
+              <Contents>A rare inherited bleeding disorder due to the reduction in activity and antigen levels of both factor V (FV) and factor VIII (FVIII) and characterized by mild-to-moderate bleeding symptoms.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -501512,7 +501884,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121388" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156316" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare neurometabolic disease characterized by infantile onset of rapidly progressive neurological deterioration, typically precipitated by a febrile illness. Patients present with hypotonia, loss of previously acquired motor milestones and cognitive skills, ataxia, nystagmus, tremor, seizures, tetraparesis, and respiratory failure, eventually resulting in a vegetative state. Imaging of the brain and spinal cord may show white matter abnormalities, cerebral atrophy, cerebellar edema, and spinal myelopathy. Subacute development of extensive bullous skin lesions within weeks of onset of neurological symptoms has also been reported.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="10506">
@@ -502857,7 +503239,17 @@
       </DisorderGroup>
       <ExternalReferenceList count="0">
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="27255" cycle="true"/>
+          <RootDisorder id="27254">
+            <OrphaCode>519394</OrphaCode>
+            <Name lang="en">OBSOLETE: Isolated microphakia</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="cs">Odkazuje na</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
         <SummaryInformation id="120142" lang="en">
@@ -502920,6 +503312,41 @@
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="27254">
+      <OrphaCode>519394</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=519394</ExpertLink>
+      <Name lang="cs">Izolovaná mikrofakie</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="455">
+          <Value>16</Value>
+          <Label>Obsolete entity</Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="0">
+      </SynonymList>
+      <DisorderType id="21415">
+        <Name lang="cs">Morfologická anomálie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="27255">
+            <OrphaCode>519396</OrphaCode>
+            <Name lang="en">Isolated microspherophakia</Name>
+          </TargetDisorder>
+          <RootDisorder id="27254" cycle="true"/>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="cs">Odkazuje na</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="11952">
       <OrphaCode>90061</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=90061</ExpertLink>
@@ -503119,7 +503546,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121393" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156321" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare hepatic disease characterized by acute onset of severe liver dysfunction without evidence of underlying chronic liver disease. Patients present with nonspecific symptoms like jaundice, upper right abdominal pain, nausea, vomiting, pruritus, fatigue, and fever. The condition may rapidly progress to hepatic encephalopathy, coagulopathy, and life-threatening multiorgan failure. Liver biopsy typically shows massive hepatic necrosis.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="27251">
@@ -510278,7 +510715,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121391" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156319" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare form of chronic cutaneous lupus erythematosus characterized by erythematous, scaly papules and plaques preferentially occurring on sun-exposed skin areas (scalp, face, and ears) and exhibiting follicular plugging, pigmentary changes, and central atrophy, scarring, and telangiectasia. Skin biopsy shows a perivascular and periadnexal lymphocytic infiltrate and involvement of the dermoepidermal junction with thickening of the basement membrane and vacuolar degeneration of the basal cells. A small percentage of patients may develop systemic lupus erythematosus.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="11992">
@@ -510544,7 +510991,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121390" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156318" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare form of chronic cutaneous lupus erythematosus characterized by recurrent, indurated, erythematous plaques and subcutaneous nodules with normal overlying epidermis, occurring predominantly on the face, upper arms, trunk, buttocks, and thighs. The lesions can ulcerate and lead to scarring. Histological findings include lobular lymphocytic panniculitis, hyaline fat necrosis, mucin deposition, and calcification. The condition may be associated with discoid or systemic lupus erythematosus.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="11999">
@@ -510677,7 +511134,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121392" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156320" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare form of chronic cutaneous lupus erythematosus characterized by extreme photosensitivity with intermittent formation of erythematous, edematous, urticarial-like, smooth plaques on sun-exposed skin areas. The lesions heal without scarring. The course of the disease is benign, and development of systemic lupus erythematosus is infrequent. Most patients do not have lupus-related autoantibodies. Skin biopsy shows a perivascular and periadnexal lymphocytic infiltrate and increased dermal mucin deposition without involvement of the dermoepidermal junction.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="11971">
@@ -515698,7 +516165,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121647" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157393" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare dendritic cell tumor characterized by a neoplasm composed of spindled to ovoid cells with phenotypic features similar to those of normal indeterminate cells. The tumor cells consistently express S100 protein and CD1a, while langerin, specific B- and T-cell markers, CD30, the histiocytic marker CD163, and the follicular dendritic cell markers CD21, CD23, and CD35 are negative. Birbeck granules are absent on ultrastructural examination. Patients typically present with multiple papules, nodules, or plaques of the skin. Primary lymph node or splenic involvement is less common. Systemic symptoms are usually absent. The clinical course is highly variable.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="27333">
@@ -515971,7 +516448,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121648" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157394" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare dendritic cell tumor characterized by a neoplasm composed of spindle to ovoid cells with phenotypic features similar to those of interdigitating dendritic cells. Solitary lymph node involvement is common, although extranodal localization (in particular skin and soft tissue) has also been reported. Patients usually present with an asymptomatic mass, sometimes with systemic symptoms such as fatigue, fever, and night sweats. Generalized lymphadenopathy, splenomegaly, or hepatomegaly may be seen in rare cases. The clinical course is generally aggressive.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="27330">
@@ -516066,7 +516553,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121641" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157386" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare dendritic cell neoplasm characterized by a proliferation of spindled to ovoid cells with morphological and immunophenotypic features of follicular dendritic cells. Conventional follicular dendritic cell sarcomas are negative for EBV. The tumor arises as a painless, slow-growing mass in lymph nodes (most often cervical), extranodal sites (such as tonsils, gastrointestinal tract, soft tissue, mediastinum, or lung, among others), or both. Paraneoplastic pemphigus may occur in rare cases. Predictive factors are tumor size, presence of coagulative necrosis, mitotic count, and presence of significant cytological atypia.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="27329">
@@ -516173,7 +516670,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121640" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157385" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare histiocytic tumor characterized by a malignant proliferation of cells showing morphological and immunophenotypic features of mature tissue histiocytes. Most cases occur in extranodal sites, most commonly the intestinal tract, skin, and soft tissue. Patients may present with a solitary mass, lymphadenopathy, a skin rash or numerous tumors on the trunk and extremities, lytic bone lesions, hepatosplenomegaly with pancytopenia, intestinal obstruction, and/or systemic symptoms. The neoplasm is aggressive with typically poor therapy response.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="27328">
@@ -516282,7 +516789,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121620" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157311" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare dendritic cell tumor characterized by an aggressive, high-grade neoplasm derived from Langerhans cells, most commonly extranodal and multifocal, involving the skin and underlying soft tissue, as well as lung, liver, spleen, and bone. Primary nodal involvement is seen in a minority of patients. Immune-phenotyping and the presence of Birbeck granules on ultrastructural examination reveal the Langerhans cell derivation of the neoplastic cells. Prognosis is generally poor.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="27320">
@@ -516543,7 +517060,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121386" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156305" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare syndromic frontonasal dysplasia characterized by distinctive facial dysmorphic features including hypertelorism, almond-shaped palpebral fissures, nasal deformity with creased ridge, depressed or absent tip, and asymmetry and partial absence of nasal bones, and downturned corners of the mouth. Additional reported manifestations are limb anomalies (e. g. Poland anomaly, transverse limb agenesis, and anomalies of the hands and feet, such as camptodactyly, oligodactyly, clinodactyly, and syndactyly), frontonasal encephalocele, choanal atresia, congenital renal/cardiac malformations, and corpus callosum agenesis.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="27324">
@@ -521829,7 +522356,17 @@
           </DisorderDisorderAssociationType>
         </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121385" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156304" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare congenital limb malformation characterized by duplication of the fifth digit in a hand or foot, the sixth digit being rudimentary, poorly developed, and non-functional, frequently consisting of additional soft tissue on a pedicle. The anomaly can be unilateral or bilateral.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="12269">
@@ -521986,7 +522523,17 @@
           </DisorderDisorderAssociationType>
         </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121384" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156303" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare congenital limb malformation characterized by duplication of the fifth digit in a hand or foot, with an extra, well-formed, functional digit at the metacarpophalangeal/metatarsophalangeal or carpometacarpal/tarsometatarsal joint. The malformation can be an isolated finding or be associated with a large number of other anomalies.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="12268">
@@ -524420,7 +524967,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121542" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157003" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare hepatic tumor characterized by the presence of both hepatocytic and cholangiocytic differentiation within a primary liver carcinoma. The lesion commonly arises in the context of chronic liver disease (such as hepatitis B or C, or steatohepatitis) or exposure to a variety of exogenous agents. Patients may present with signs and symptoms related to the tumor, as well as to the underlying condition. Typical manifestations include right upper quadrant abdominal pain, weight loss, hepatosplenomegaly, jaundice, and ascites. The entity has been associated with a worse prognosis than hepatocellular carcinoma after resection.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="12074">
@@ -548264,7 +548821,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome is characterised by severe intellectual deficit, hypotonia, mild facial dysmorphism, and aggressive behaviour. It has been described in 10 male members spanning four generations of one family. The facial dysmorphism includes a high forehead, prominent ears, and a small pointed chin. Height and head circumference are reduced. This disorder is transmitted as an X-linked recessive trait and the causative gene maps to Xp22.</Contents>
+              <Contents>A rare X-linked syndromic intellectual disability characterized by severe to profound intellectual disability, muscular hypotonia in childhood, delayed walking, delayed or minimal/absent speech, behavioral abnormalities including aggressiveness, agitation, and self-injurious behavior, and dysmorphic facial features (such as triangular face with high forehead, prominent ears, and small, pointed chin). Additional reported manifestations include microcephaly, short stature, and seizures, among others.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -548861,7 +549418,27 @@
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="2">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="11710" cycle="true"/>
+          <RootDisorder id="19555">
+            <OrphaCode>247839</OrphaCode>
+            <Name lang="en">OBSOLETE: Oligoarticular juvenile idiopathic arthritis with anti-nuclear antibodies</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="cs">Odkazuje na</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="11710" cycle="true"/>
+          <RootDisorder id="19556">
+            <OrphaCode>247846</OrphaCode>
+            <Name lang="en">OBSOLETE: Oligoarticular juvenile idiopathic arthritis without anti-nuclear antibodies</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="cs">Odkazuje na</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
         <SummaryInformation id="45226" lang="en">
@@ -549057,7 +549634,17 @@
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="11709" cycle="true"/>
+          <RootDisorder id="19558">
+            <OrphaCode>247861</OrphaCode>
+            <Name lang="en">OBSOLETE: Rheumatoid factor-negative juvenile idiopathic arthritis without anti-nuclear antibodies</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="cs">Odkazuje na</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
       <SummaryInformationList count="1">
         <SummaryInformation id="45220" lang="en">
@@ -551371,7 +551958,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121652" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157398" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare unclassified acute myeloid leukemia characterized by an acute panmyeloid proliferation with blasts constituting more than 20% of cells in the bone marrow or peripheral blood, accompanied by fibrosis of the bone marrow. Patients typically present with acute onset of severe constitutional symptoms, bone pain, and pancytopenia. Splenomegaly is minimal or absent. The disease is rapidly progressive with poor therapy response.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="11750">
@@ -551443,7 +552040,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121655" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157409" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare myelodysplastic syndrome characterized by macrocytic anemia (with or without other cytopenias and/or thrombocytosis), and with del(5q) occurring either in isolation, or with one other cytogenetic abnormality, other than monosomy 7 or del(7q). The bone marrow is typically hypercellular with erythroid hypoplasia and increased numbers of megakaryocytes, which show non-lobated and hypolobated nuclei. Myeloblasts constitute less than 5% of the nucleated bone marrow cells and less than 1% of the peripheral blood leukocytes. Auer rods are absent. Ring sideroblasts may be observed. Patients present with anemia and often thrombocytosis, while thrombocytopenia or pancytopenia are uncommon. Transformation to acute myeloid leukemia may occur in a small number of patients.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="11749">
@@ -551715,7 +552322,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121589" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157266" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare myelodysplastic/myeloproliferative neoplasm characterized by a proliferation primarily of granulocytic and monocytic lineages with infiltration of the liver and spleen, among other organs. Blasts and promonocytes account for less than 20% of white blood cells in peripheral blood and bone marrow. Erythroid and megakaryocytic abnormalities are often present. BCR-ABL1 fusion is absent, while somatic mutations in genes of the RAS pathway or monosomy 7 may be found. The condition may also occur in the context of neurofibromatosis type 1 or Noonan syndrome-like disorder. Children of less than three years are predominantly affected, with a clear male preponderance. Most patients present with constitutional symptoms, signs of infection, and hepatosplenomegaly.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="11745">
@@ -551836,7 +552453,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121639" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157384" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare myeloproliferative neoplasm characterized by sustained peripheral blood neutrophilia, bone marrow hypercellularity due to neutrophilic granulocyte proliferation, and hepatosplenomegaly. Other organs may be infiltrated in addition. Microscopically, the bone marrow shows an increase in proportion of myelocytes and mature neutrophils, but no significant dysplasia in any of the cell lineages. Peripheral blood neutrophils are mostly segmented, although band forms may also be substantially increased. Cytogenetic abnormalities are absent in most cases. The disease is slowly progressive with progredient neutrophilia followed by anemia and thrombocytopenia. Transformation to acute myeloid leukemia may occur.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="11759">
@@ -552111,7 +552738,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121657" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157419" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare mature B-cell neoplasm characterized by clonal proliferation of B-cell prolymphocytes, with prolymphocytes constituting more than 55% of lymphoid cells in peripheral blood. IG genes are clonally rearranged. Neoplastic cells are present in the bone marrow, peripheral blood, and spleen. Patients usually present with B symptoms, massive splenomegaly but absent or minimal lymphadenopathy, rapidly increasing lymphocyte count, anemia, and thrombocytopenia. Therapy response is poor.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="11756">
@@ -552341,7 +552978,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121569" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157230" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare acute myeloid leukemia characterized by primary differentiation to basophils. Microscopically, peripheral blood and bone marrow blasts contain coarse cytoplasmic basophilic granules which are positive with metachromatic staining (toluidine blue). Electron microscopy confirms that granules show features characteristic of basophil precursors. Mature basophils are usually sparse. Patients may present with manifestations related to bone marrow failure, as well as hepatosplenomegaly, cutaneous involvement, lytic lesions, and hyperhistaminemia. The disease is associated with a poor prognosis.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="11753">
@@ -552769,7 +553416,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121658" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157424" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare mature T-cell neoplasm characterized by proliferation of small to medium-sized prolymphocytes with a mature post-thymic T-cell phenotype, involving the peripheral blood, bone marrow, lymph nodes, liver, spleen, and sometimes the skin. T-cell receptor genes are clonally rearranged. Patients typically present with hepatosplenomegaly, generalized lymphadenopathy, high leukocyte count with normal serum immunoglobulins, anemia, and thrombocytopenia. HTLV-1 serology is negative. The disease course is aggressive with generally poor prognosis.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="11762">
@@ -553120,7 +553777,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121622" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157313" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare T-cell non-Hodgkin lymphoma characterized by infiltration of lymph nodes by neoplastic cells of T follicular helper cell origin with a polymorphous inflammatory background including markedly increased follicular dendritic cells and EBV-positive B-cells, as well as prominent proliferation of high endothelial venules. The spleen, liver, skin, and bone marrow are also frequently involved. Patients typically present with generalized lymphadenopathy, hepatosplenomegaly, systemic symptoms, and polyclonal hypergammaglobulinemia. Pruritic skin rash, arthritis, pleural effusion, and ascites may also be observed. The condition is aggressive with generally poor prognosis.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="11775">
@@ -553432,7 +554099,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121621" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157312" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare T-cell non-Hodgkin lymphoma characterized by a neoplasm of intraepithelial T-cells mostly occurring in the jejunum or ileum in patients with celiac disease. The lesion may be multifocal and form ulcerating nodules, plaques, strictures, or an exophytic mass. The mesentery and mesenteric lymph nodes are commonly involved. Patients typically present with abdominal pain, malabsorption or diarrhea, anorexia, weight loss, fatigue, nausea, vomiting, and sometimes intestinal perforation or hemorrhage. Prognosis is generally poor.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="11771">
@@ -553492,7 +554169,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121670" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157543" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare T-cell non-Hodgkin lymphoma characterized by a proliferation of cytotoxic T-cells, usually gamma delta T-cells, with involvement of the liver and spleen, but without involvement of lymph nodes. The bone marrow is consistently affected. Patients typically present during adolescence or young adulthood with hepatosplenomegaly, pancytopenia, and systemic symptoms. Peripheral blood involvement may develop later in the disease course. There is a clear male preponderance. The disease often occurs in the context of long-term immunosuppression. The course is aggressive with poor therapy response.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="11768">
@@ -557267,7 +557954,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>A syndrome that combines agammaglobulinemia with marked microcephaly, significant developmental delay, craniosynostosis, a severe dermatitis, cleft palate, narrowing of the choanae, and blepharophimosis. It has been described in three siblings, two males and one female, born to nonconsanguineous parents. Transmission is probably autosomal recessive. It has been suggested that this syndrome represents a new form of agammaglobulinemia due to a defect in early B-cell maturation.</Contents>
+              <Contents>A rare syndromic agammaglobulinemia characterized by profound B-cell depletion (with normal T-cell numbers) resulting in agammaglobulinemia, associated with severe developmental delay, microcephaly, craniosynostosis, cleft palate, narrowing of the choanae, blepharophimosis, and severe dermatitis. Additional reported features include distal joint contractures, renal/genitourinary anomalies, and mild cerebral atrophy, among others.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -565276,7 +565963,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121721" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157764" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare primary organ-specific lymphoma characterized by primary origin in the thyroid gland, sometimes involving cervical lymph nodes, and infrequently more distant sites. Diffuse large B-cell lymphoma is most common, followed by MALT lymphoma, and follicular lymphoma. More rare types include T-cell lymphomas, Burkitt lymphoma, or classic Hodgkin lymphoma. The condition is usually associated with Hashimoto thyroiditis. Patients typically present with a mass in the thyroid, with or without cervical lymphadenopathy. Hoarseness and dyspnea may occur, while constitutional symptoms are rare. Prognosis is favorable for patients with localized tumors.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="12878">
@@ -585854,7 +586551,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Brachydactyly type B (BDB) is a very rare congenital malformation characterized by hypoplasia or aplasia of the terminal parts of fingers 2 to 5, with complete absence of the fingernails.</Contents>
+              <Contents>A rare congenital limb malformation syndrome characterized by hypoplasia or aplasia of the terminal parts of fingers 2 to 5, with complete absence of the fingernails. The thumbs are always intact but frequently show flattening, splitting or duplication of the distal phalanges. Digits on the radial side of the hand are less severely affected than those on the ulnar side. The feet are similarly affected but less severely. Soft tissue syndactyly, symphalangism, carpal and/or tarsal fusions and shortening of metacarpals and/or metatarsals may be present.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -589927,9 +590624,9 @@
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
       <ExternalReferenceList count="1">
-        <ExternalReference id="117495">
+        <ExternalReference id="185251">
           <Source>ICD-10</Source>
-          <Reference>D36.0</Reference>
+          <Reference>D47.7</Reference>
           <DisorderMappingRelation id="21534">
             <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
           </DisorderMappingRelation>
@@ -597196,6 +597893,32 @@
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29460">
+      <OrphaCode>590539</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=590539</ExpertLink>
+      <Name lang="cs">Leberova choroba plus</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="1">
+        <Synonym lang="cs">LHON+</Synonym>
+      </SynonymList>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="14295">
       <OrphaCode>99722</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=99722</ExpertLink>
@@ -597362,6 +598085,94 @@
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29441">
+      <OrphaCode>589821</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=589821</ExpertLink>
+      <Name lang="cs">Pituitární gigantismus</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="2">
+        <Synonym lang="cs">Hypofyzární gigantismus</Synonym>
+        <Synonym lang="cs">Infantilní a juvenilní formy akromegalie</Synonym>
+      </SynonymList>
+      <DisorderType id="21450">
+        <Name lang="cs">Klinický podtyp</Name>
+      </DisorderType>
+      <DisorderGroup id="36554">
+        <Name lang="en">Subtype of disorder</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
+    <Disorder id="29440">
+      <OrphaCode>589746</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=589746</ExpertLink>
+      <Name lang="cs">Pituitární gigantismus</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="2">
+        <Synonym lang="cs">Hypofyzární gigantismus</Synonym>
+        <Synonym lang="cs">Infantilní a juvenilní formy akromegalie</Synonym>
+      </SynonymList>
+      <DisorderType id="21436">
+        <Name lang="en">Clinical group</Name>
+      </DisorderType>
+      <DisorderGroup id="36540">
+        <Name lang="en">Group of disorders</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="cs">Tento termín neoznačuje nemoc, ale skupinu nemocí. Chcete-li se dozvědět o nemocech zahrnutých v tomto termínu, můžete se obrátit na klasifikace.</Info>
+          </TextAuto>
+        </SummaryInformation>
+      </SummaryInformationList>
+    </Disorder>
+    <Disorder id="29443">
+      <OrphaCode>589827</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=589827</ExpertLink>
+      <Name lang="cs">Pituitární gigantismus</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="2">
+        <Synonym lang="cs">Hypofyzární gigantismus</Synonym>
+        <Synonym lang="cs">Infantilní a juvenilní formy akromegalie</Synonym>
+      </SynonymList>
+      <DisorderType id="21450">
+        <Name lang="cs">Klinický podtyp</Name>
+      </DisorderType>
+      <DisorderGroup id="36554">
+        <Name lang="en">Subtype of disorder</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="14274">
       <OrphaCode>99701</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=99701</ExpertLink>
@@ -597398,6 +598209,139 @@
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29442">
+      <OrphaCode>589824</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=589824</ExpertLink>
+      <Name lang="cs">Meziální temporální epilepsie s hipokampální sklerózou</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="2">
+        <Synonym lang="en">Childhood-onset Steinert disease</Synonym>
+        <Synonym lang="en">Childhood-onset myotonic dystrophy type 1</Synonym>
+      </SynonymList>
+      <DisorderType id="21450">
+        <Name lang="cs">Klinický podtyp</Name>
+      </DisorderType>
+      <DisorderGroup id="36554">
+        <Name lang="en">Subtype of disorder</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
+    <Disorder id="29445">
+      <OrphaCode>589833</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=589833</ExpertLink>
+      <Name lang="cs">Meziální temporální epilepsie s hipokampální sklerózou</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="2">
+        <Synonym lang="en">Late-onset Steinert disease</Synonym>
+        <Synonym lang="en">Late-onset myotonic dystrophy type 1</Synonym>
+      </SynonymList>
+      <DisorderType id="21450">
+        <Name lang="cs">Klinický podtyp</Name>
+      </DisorderType>
+      <DisorderGroup id="36554">
+        <Name lang="en">Subtype of disorder</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
+    <Disorder id="29444">
+      <OrphaCode>589830</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=589830</ExpertLink>
+      <Name lang="cs">Meziální temporální epilepsie s hipokampální sklerózou</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="2">
+        <Synonym lang="en">Adult-onset Steinert disease</Synonym>
+        <Synonym lang="en">Adult-onset myotonic dystrophy type 1</Synonym>
+      </SynonymList>
+      <DisorderType id="21450">
+        <Name lang="cs">Klinický podtyp</Name>
+      </DisorderType>
+      <DisorderGroup id="36554">
+        <Name lang="en">Subtype of disorder</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
+    <Disorder id="29447">
+      <OrphaCode>589905</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=589905</ExpertLink>
+      <Name lang="cs">Meziální temporální epilepsie s hipokampální sklerózou</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="1">
+        <Synonym lang="en">Chung-Jansen syndrome</Synonym>
+      </SynonymList>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
+    <Disorder id="29446">
+      <OrphaCode>589856</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=589856</ExpertLink>
+      <Name lang="cs">Meziální temporální epilepsie s hipokampální sklerózou</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="1">
+        <Synonym lang="en">KMT2D-related choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome</Synonym>
+      </SynonymList>
+      <DisorderType id="21401">
+        <Name lang="cs">Malformační syndrom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="14279">
       <OrphaCode>99706</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=99706</ExpertLink>
@@ -600041,7 +600985,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121651" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157397" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare myelodysplastic/myeloproliferative neoplasm characterized by clinical, laboratory, and morphological features of both myelodysplastic syndrome and myeloproliferative neoplasm at onset, in the absence of recent cytotoxic or growth factor therapy, and without Philadelphia chromosome, BCR-ABL1 or PCM1-JAK2 fusion, or rearrangement of PDGFRA, PDGFRB, or FGFR1. Cases of a previously well-defined myeloproliferative neoplasm developing dysplastic features are excluded, and the criteria for any other myelodysplastic/myeloproliferative neoplasm, myelodysplastic syndrome, or myeloproliferative neoplasm are not met.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="13843">
@@ -600194,7 +601148,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121572" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157233" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare myelodysplastic/myeloproliferative neoplasm characterized by a spectrum of clinical, hematological, and morphological features, ranging from predominantly myelodysplastic to mainly myeloproliferative in nature. Infiltration of the liver, spleen, lymph nodes, and other organs is common. Persistent peripheral blood monocytosis with monocytes accounting for more than 10% of leukocytes is the hallmark of the condition. Blasts constitute less than 20% of the cells in the peripheral blood and bone marrow. Other abnormalities are variable. Patients may present with constitutional symptoms, signs and symptoms of hematopoietic insufficiency, and hepatosplenomegaly. The disease is associated with a risk of transformation to acute myeloid leukemia.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="13841">
@@ -600277,7 +601241,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121570" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157231" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare myelodysplastic/myeloproliferative neoplasm characterized by peripheral blood leukocytosis due to increased numbers of morphologically dysplastic neutrophils and their precursors, hypercellular bone marrow with granulocytic proliferation and dysplasia (with or without dysplasia in the erythroid and megakaryocytic lineages), and prominent dysgranulopoiesis, but no or minimal absolute basophilia or monocytosis. Blasts account for less than 20% of leukocytes in the blood and bone marrow. BCR-ABL1 fusion is absent, as well as PDGFRA, PDGFRB or FGFR1 rearrangement, or PCM1-JAK2. Patients may present with signs and symptoms related to splenomegaly, anemia, or thrombocytopenia. Prognosis is generally poor.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="13869">
@@ -601254,6 +602228,36 @@
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29437">
+      <OrphaCode>589608</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=589608</ExpertLink>
+      <Name lang="cs">Anaplastický velkobuněčný lymfom</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="5">
+        <Synonym lang="cs">ALCL</Synonym>
+        <Synonym lang="cs">CD30 pozitivní anaplastický velkobuněčný lymfom</Synonym>
+        <Synonym lang="cs">Ki-1 pozitivní anaplastický velkobuněčný lymfom</Synonym>
+        <Synonym lang="cs">Primární systémový ALCL</Synonym>
+        <Synonym lang="cs">sACL</Synonym>
+      </SynonymList>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="13884">
       <OrphaCode>98867</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=98867</ExpertLink>
@@ -601335,6 +602339,33 @@
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29436">
+      <OrphaCode>589595</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=589595</ExpertLink>
+      <Name lang="cs">Hereditární pyropoikilocytóza</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="2">
+        <Synonym lang="en">MPAL with t(v;11q23.3); KMT2A rearranged</Synonym>
+        <Synonym lang="en">MPAL with t(v;11q23.3); MLL rearranged</Synonym>
+      </SynonymList>
+      <DisorderType id="21443">
+        <Name lang="cs">Etiologický podtyp</Name>
+      </DisorderType>
+      <DisorderGroup id="36554">
+        <Name lang="en">Subtype of disorder</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="13885">
       <OrphaCode>98868</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=98868</ExpertLink>
@@ -601484,6 +602515,35 @@
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29438">
+      <OrphaCode>589618</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=589618</ExpertLink>
+      <Name lang="cs">Vrozená dyserytropoetická anémie, typ I</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="4">
+        <Synonym lang="cs">CDA I</Synonym>
+        <Synonym lang="cs">CDA typ 1</Synonym>
+        <Synonym lang="cs">CDA typ I</Synonym>
+        <Synonym lang="cs">Vrozená dyserytropoetická anémie, typ 1</Synonym>
+      </SynonymList>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="13887">
       <OrphaCode>98870</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=98870</ExpertLink>
@@ -601558,6 +602618,35 @@
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29433">
+      <OrphaCode>589534</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=589534</ExpertLink>
+      <Name lang="cs">Vrozená dyserytropoetická anémie, typ III</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="4">
+        <Synonym lang="cs">CDA III</Synonym>
+        <Synonym lang="cs">CDA typ 3</Synonym>
+        <Synonym lang="cs">CDA typ III</Synonym>
+        <Synonym lang="cs">Vrozená dyserytropoetická anémie, typ 3</Synonym>
+      </SynonymList>
+      <DisorderType id="21443">
+        <Name lang="cs">Etiologický podtyp</Name>
+      </DisorderType>
+      <DisorderGroup id="36554">
+        <Name lang="en">Subtype of disorder</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="13880">
       <OrphaCode>98863</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=98863</ExpertLink>
@@ -601638,6 +602727,33 @@
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29432">
+      <OrphaCode>589527</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=589527</ExpertLink>
+      <Name lang="cs">X-vázaná Emeryho-Dreifussova svalová dystrofie</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="2">
+        <Synonym lang="cs">EDMD1</Synonym>
+        <Synonym lang="cs">Emerinopatie</Synonym>
+      </SynonymList>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="13881">
       <OrphaCode>98864</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=98864</ExpertLink>
@@ -601697,6 +602813,31 @@
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29435">
+      <OrphaCode>589547</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=589547</ExpertLink>
+      <Name lang="cs">Běžná hereditární eliptocytóza</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="0">
+      </SynonymList>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="13882">
       <OrphaCode>98865</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=98865</ExpertLink>
@@ -601756,6 +602897,32 @@
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29434">
+      <OrphaCode>589542</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=589542</ExpertLink>
+      <Name lang="cs">Homozygotní hereditární eliptocytóza</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="1">
+        <Synonym lang="en">Myeloid/lymphoid neoplasms with PCM1-JAK2</Synonym>
+      </SynonymList>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="13883">
       <OrphaCode>98866</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=98866</ExpertLink>
@@ -601791,6 +602958,84 @@
       <SummaryInformationList count="0">
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29429">
+      <OrphaCode>589442</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=589442</ExpertLink>
+      <Name lang="cs">Homozygotní hereditární eliptocytóza</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="1">
+        <Synonym lang="en">Liberfarb syndrome</Synonym>
+      </SynonymList>
+      <DisorderType id="21401">
+        <Name lang="cs">Malformační syndrom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
+    <Disorder id="29428">
+      <OrphaCode>589435</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=589435</ExpertLink>
+      <Name lang="cs">Homozygotní hereditární eliptocytóza</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="1">
+        <Synonym lang="en">SMD-corneal dystrophy syndrome</Synonym>
+      </SynonymList>
+      <DisorderType id="21401">
+        <Name lang="cs">Malformační syndrom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
+    <Disorder id="29431">
+      <OrphaCode>589522</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=589522</ExpertLink>
+      <Name lang="cs">Homozygotní hereditární eliptocytóza</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="1">
+        <Synonym lang="en">SCA46</Synonym>
+      </SynonymList>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="13878">
       <OrphaCode>98861</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=98861</ExpertLink>
@@ -601863,6 +603108,35 @@
         </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="29430">
+      <OrphaCode>589515</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=589515</ExpertLink>
+      <Name lang="cs">Primární ciliární dyskineze, Kartagenerův typ</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="475">
+          <Value>1</Value>
+          <Label></Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="4">
+        <Synonym lang="cs">Syndrom zahrnující dextrokardii, bronchiektázii a sinusitidu</Synonym>
+        <Synonym lang="cs">Syndrom nepohyblivých řasinek, Kartagenerův typ</Synonym>
+        <Synonym lang="cs">Kartagenerův syndrom</Synonym>
+        <Synonym lang="cs">Siewertův syndrom</Synonym>
+      </SynonymList>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="0">
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="13872">
       <OrphaCode>98855</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=98855</ExpertLink>
@@ -604614,7 +605888,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121475" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="156811" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A form of neutral lipid storage disease characterized by the accumulation of lipid vacuoles in leukocytes (so-called Jordan's anomaly seen in peripheral blood smears) and a variety of other cell types. The clinical picture consists of congenital ichthyosis of the congenital ichthyosiform erythroderma type together with variable multisystem involvement. Manifestations include hepatosplenomegaly, myopathy, intestinal disease, growth retardation, cataracts, sensorineural hearing loss, and intellectual disability, among others.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="13927">
@@ -610157,7 +611441,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>A rare, slowly progressive neurological disorder involving centralnervous systemdemyelination, leading to autonomic dysfunction, ataxia and mild cognitive impairment.</Contents>
+              <Contents>A rare, slowly progressive neurological disorder involving central nervous system demyelination, leading to autonomic dysfunction, ataxia and mild cognitive impairment.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -612101,6 +613385,41 @@
       <SummaryInformationList count="0">
       </SummaryInformationList>
     </Disorder>
+    <Disorder id="13610">
+      <OrphaCode>98593</OrphaCode>
+      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=98593</ExpertLink>
+      <Name lang="cs">Neurogenní nádor víček</Name>
+      <DisorderFlagList count="1">
+        <DisorderFlag id="455">
+          <Value>16</Value>
+          <Label>Obsolete entity</Label>
+        </DisorderFlag>
+      </DisorderFlagList>
+      <SynonymList count="0">
+      </SynonymList>
+      <DisorderType id="21394">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="cs">Onemocnění</Name>
+      </DisorderGroup>
+      <ExternalReferenceList count="0">
+      </ExternalReferenceList>
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="14886">
+            <OrphaCode>101950</OrphaCode>
+            <Name lang="en">Rare eye tumor</Name>
+          </TargetDisorder>
+          <RootDisorder id="13610" cycle="true"/>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="cs">Odkazuje na</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
+      </DisorderDisorderAssociationList>
+      <SummaryInformationList count="0">
+      </SummaryInformationList>
+    </Disorder>
     <Disorder id="13609">
       <OrphaCode>98592</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=98592</ExpertLink>
@@ -625091,7 +626410,14 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="cs">Toto onemocnění je popsáno v  Metabolická myopatie</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="13446">
@@ -625441,7 +626767,14 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="cs">Toto onemocnění je popsáno v  Anomálie inhibitoru proteázy</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="28755">
@@ -625479,7 +626812,14 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="cs">Toto onemocnění je popsáno v  Anomálie inhibitoru proteázy</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="28766">
@@ -626195,7 +627535,14 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="cs">Toto onemocnění je popsáno v  Ataxie s demencí</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="13566">
@@ -626548,7 +627895,20 @@
       <DisorderGroup id="36554">
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="0">
+      <ExternalReferenceList count="1">
+        <ExternalReference id="185253">
+          <Source>ICD-10</Source>
+          <Reference>D47.7</Reference>
+          <DisorderMappingRelation id="21534">
+            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="cs">Ověřeno</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
@@ -626575,7 +627935,20 @@
       <DisorderGroup id="36554">
         <Name lang="en">Subtype of disorder</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="0">
+      <ExternalReferenceList count="1">
+        <ExternalReference id="185252">
+          <Source>ICD-10</Source>
+          <Reference>D47.7</Reference>
+          <DisorderMappingRelation id="21534">
+            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
+          </DisorderMappingRelation>
+          <DisorderMappingICDRelation id="21604">
+            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
+          </DisorderMappingICDRelation>
+          <DisorderMappingValidationStatus id="21611">
+            <Name lang="cs">Ověřeno</Name>
+          </DisorderMappingValidationStatus>
+        </ExternalReference>
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
@@ -628098,7 +629471,7 @@
               <TextSectionType id="16907">
                 <Name lang="cs">Definice</Name>
               </TextSectionType>
-              <Contents>Congenital sodium diarrhea is characterized by severe watery diarrhea containing high concentrations of sodium, hyponatremia and metabolic acidosis.</Contents>
+              <Contents>A rare, genetic, non-syndromic intestinal transport defect characterized by congenital onset of severe watery diarrhea containing high concentrations of sodium, hyponatremia and metabolic acidosis.</Contents>
             </TextSection>
           </TextSectionList>
         </SummaryInformation>
@@ -632168,7 +633541,7 @@
           </DisorderMappingValidationStatus>
         </ExternalReference>
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="14">
+      <DisorderDisorderAssociationList count="15">
         <DisorderDisorderAssociation>
           <TargetDisorder id="14886" cycle="true"/>
           <RootDisorder id="13597">
@@ -632279,6 +633652,16 @@
             <Name lang="cs">Odkazuje na</Name>
           </DisorderDisorderAssociationType>
         </DisorderDisorderAssociation>
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="14886" cycle="true"/>
+          <RootDisorder id="13610">
+            <OrphaCode>98593</OrphaCode>
+            <Name lang="en">OBSOLETE: Neurogenic palpebral tumor</Name>
+          </RootDisorder>
+          <DisorderDisorderAssociationType id="27341">
+            <Name lang="cs">Odkazuje na</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
         <DisorderDisorderAssociation>
           <TargetDisorder id="14886" cycle="true"/>
           <RootDisorder id="13633">
@@ -647695,7 +649078,11 @@
       <OrphaCode>99900</OrphaCode>
       <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=99900</ExpertLink>
       <Name lang="cs">Deficit  dehydrogenázy acyl-CoA s dlouhým řetězcem</Name>
-      <DisorderFlagList count="1">
+      <DisorderFlagList count="2">
+        <DisorderFlag id="459">
+          <Value>256</Value>
+          <Label>Deprecated entity</Label>
+        </DisorderFlag>
         <DisorderFlag id="475">
           <Value>1</Value>
           <Label></Label>
@@ -647710,7 +649097,7 @@
       <DisorderGroup id="36547">
         <Name lang="cs">Onemocnění</Name>
       </DisorderGroup>
-      <ExternalReferenceList count="3">
+      <ExternalReferenceList count="2">
         <ExternalReference id="119285">
           <Source>MeSH</Source>
           <Reference>C535690</Reference>
@@ -647733,23 +649120,27 @@
             <Name lang="cs">Ověřeno</Name>
           </DisorderMappingValidationStatus>
         </ExternalReference>
-        <ExternalReference id="119288">
-          <Source>ICD-10</Source>
-          <Reference>E71.3</Reference>
-          <DisorderMappingRelation id="21534">
-            <Name lang="en">NTBT (ORPHA code's Narrower Term maps to a Broader Term)</Name>
-          </DisorderMappingRelation>
-          <DisorderMappingICDRelation id="21604">
-            <Name lang="en">Attributed (The ICD10 code is attributed by Orphanet)</Name>
-          </DisorderMappingICDRelation>
-          <DisorderMappingValidationStatus id="21611">
-            <Name lang="cs">Ověřeno</Name>
-          </DisorderMappingValidationStatus>
-        </ExternalReference>
       </ExternalReferenceList>
-      <DisorderDisorderAssociationList count="0">
+      <DisorderDisorderAssociationList count="1">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id="8768">
+            <OrphaCode>26793</OrphaCode>
+            <Name lang="en">Very long chain acyl-CoA dehydrogenase deficiency</Name>
+          </TargetDisorder>
+          <RootDisorder id="14473" cycle="true"/>
+          <DisorderDisorderAssociationType id="21471">
+            <Name lang="cs">Přesunuto do</Name>
+          </DisorderDisorderAssociationType>
+        </DisorderDisorderAssociation>
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="-1" lang="en">
+          <TextSectionList count="0">
+          </TextSectionList>
+          <TextAuto>
+            <Info lang="cs">Toto onemocnění bylo přesunuto do  Deficit  dehydrogenázy acyl-CoA s dlouhým řetězcem</Info>
+          </TextAuto>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="14478">
@@ -649163,7 +650554,17 @@
       </ExternalReferenceList>
       <DisorderDisorderAssociationList count="0">
       </DisorderDisorderAssociationList>
-      <SummaryInformationList count="0">
+      <SummaryInformationList count="1">
+        <SummaryInformation id="121720" lang="en">
+          <TextSectionList count="1">
+            <TextSection id="157763" lang="en">
+              <TextSectionType id="16907">
+                <Name lang="cs">Definice</Name>
+              </TextSectionType>
+              <Contents>A rare acute lymphoblastic leukemia characterized by a neoplasm of lymphoblasts committed to the T-cell lineage, involving bone marrow and blood. A value of &gt;25% bone marrow blasts may be used to define leukemia (as opposed to lymphoma) in cases with the presence of a mass lesion in addition to bone marrow involvement. Patients typically present with leukocytosis, and frequently with a large mediastinal or other tissue mass. Lymphadenopathy and hepatosplenomegaly are common.</Contents>
+            </TextSection>
+          </TextSectionList>
+        </SummaryInformation>
       </SummaryInformationList>
     </Disorder>
     <Disorder id="14445">
